**Data Dictionary**

**Limited Access Dataset for Aspirin Myocardial Infarction Study
(AMIS)**

Dataset Baseline

Number of Observations: 4524

Number of Variables: 137

Created Date: October 14, 2004

+-----+------+----+---+--------+--------------------------------------+
| **A |      |    |   |        |                                      |
| lph |      |    |   |        |                                      |
| abe |      |    |   |        |                                      |
| tic |      |    |   |        |                                      |
| L   |      |    |   |        |                                      |
| ist |      |    |   |        |                                      |
| of  |      |    |   |        |                                      |
| Var |      |    |   |        |                                      |
| iab |      |    |   |        |                                      |
| les |      |    |   |        |                                      |
| and |      |    |   |        |                                      |
| Att |      |    |   |        |                                      |
| rib |      |    |   |        |                                      |
| ute |      |    |   |        |                                      |
| s** |      |    |   |        |                                      |
+=====+======+====+===+========+======================================+
| **P | **Va | ** | * | **Fo   | **Label**                            |
| osi | riab | Ty | * | rmat** |                                      |
| tio | le** | pe | L |        |                                      |
| n** |      | ** | e |        |                                      |
|     |      |    | n |        |                                      |
|     |      |    | * |        |                                      |
|     |      |    | * |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **  | age  | N  | 8 |        | Age at Randomization                 |
| 3** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | agec | N  | 8 | CL     | Collapsed Value                      |
| *13 |      | um |   | LPSEF. |                                      |
| 2** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **1 | bl08 | N  | 8 |        | Age at Most Recent MI                |
| 5** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **2 | bl11 | N  | 8 | DNSF.  | Experienced Angina Pectoris          |
| 2** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **2 | bl12 | N  | 8 | NYHAF. | NY Heart Assoc. Class                |
| 3** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **3 | bl14 | N  | 8 | YNF.   | Patient Ever Had Definite/Suspect    |
| 3** |      | um |   |        | ICIA?                                |
+-----+------+----+---+--------+--------------------------------------+
| **3 | bl15 | N  | 8 | YNF.   | Patient Ever Had Definite/Suspect    |
| 4** |      | um |   |        | Intermittent Claudication?           |
+-----+------+----+---+--------+--------------------------------------+
| **4 | bl19 | N  | 8 | WRKF.  | Work Status                          |
| 3** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **4 | bl20 | N  | 8 | L      | Life Style                           |
| 4** |      | um |   | FSTLF. |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **4 | bl21 | N  | 8 | YNF.   | Patient Ever Forced to Change        |
| 5** |      | um |   |        | Lifestyle                            |
+-----+------+----+---+--------+--------------------------------------+
| **4 | bl22 | N  | 8 | CFNF.  | Cigarette Smoker                     |
| 6** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **4 | bl23 | N  | 8 | YR     | Years a Smoker                       |
| 7** |      | um |   | SMKRF. |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **4 | bl24 | N  | 8 | S      | Average No. Smoked Per Day           |
| 8** |      | um |   | MKPDF. |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **4 | bl25 | N  | 8 | CS     | Currently Smoke Per Day              |
| 9** |      | um |   | MKPDF. |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **5 | bl26 | N  | 8 |        | Estimated Age Smoking Stopped        |
| 0** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **5 | bl27 | N  | 8 | CFNF.  | Cigar Smoker                         |
| 1** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **5 | bl28 | N  | 8 | CFNF.  | Pipe Smoker                          |
| 2** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **5 | bl30 | N  | 8 | YNF.   | Consumes \> 1.5 oz. Pure Ethyl       |
| 3** |      | um |   |        | Alcohol Per Day                      |
+-----+------+----+---+--------+--------------------------------------+
| **7 | bl35 | N  | 8 |        | Height (inches)                      |
| 6** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **7 | bl36 | N  | 8 |        | Weight (lbs.)                        |
| 7** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **8 | bl38 | N  | 8 |        | Pulse Rate: beats per minute         |
| 0** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **8 | bl49 | N  | 8 |        | Hematocrit (%)                       |
| 5** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **8 | bl51 | N  | 8 | NPF.   | Hematuria                            |
| 6** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **8 | bl52 | N  | 8 | NPF.   | Urine Glucose                        |
| 7** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **8 | bl53 | N  | 8 | U      | Urine Protien                        |
| 8** |      | um |   | RPRTF. |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **1 | b    | N  | 8 |        | Yr. uncertain                        |
| 6** | l08a | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **1 | b    | N  | 8 | DNSF.  | Ever Had Stroke                      |
| 7** | l10a | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **1 | b    | N  | 8 | DNSF.  | Ever Had Pulmonary Embolism          |
| 8** | l10b | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **1 | b    | N  | 8 | DNSF.  | Ever Had Peripheral Arterial         |
| 9** | l10c | um |   |        | Occlusion                            |
+-----+------+----+---+--------+--------------------------------------+
| **2 | b    | N  | 8 | DNSF.  | Ever Had Heart Failure               |
| 0** | l10d | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **2 | b    | N  | 8 | DNF.   | Ever Had Coronary Arteriography      |
| 1** | l10e | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **2 | b    | N  | 8 | YNF.   | Documented by ECG: Atrial Flutter of |
| 4** | l13a | um |   |        | Fibrillation                         |
+-----+------+----+---+--------+--------------------------------------+
| **2 | b    | N  | 8 | YNF.   | Documented by ECG: Atrial            |
| 5** | l13b | um |   |        | Tachycardia                          |
+-----+------+----+---+--------+--------------------------------------+
| **2 | b    | N  | 8 | YNF.   | Documented by ECG: Functional        |
| 6** | l13c | um |   |        | Tachycardia                          |
+-----+------+----+---+--------+--------------------------------------+
| **2 | b    | N  | 8 | YNF.   | Documented by ECG: Ventricular       |
| 7** | l13d | um |   |        | Tachycardia                          |
+-----+------+----+---+--------+--------------------------------------+
| **2 | b    | N  | 8 | YNF.   | Documented by ECG: Multifocal (PVCs) |
| 8** | l13e | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **2 | b    | N  | 8 | YNF.   | Documented by ECG: Frequent PVCs     |
| 9** | l13f | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **3 | b    | N  | 8 | YNF.   | Documented by ECG: Second Degree A-V |
| 0** | l13g | um |   |        | Block                                |
+-----+------+----+---+--------+--------------------------------------+
| **3 | b    | N  | 8 | YNF.   | Documented by ECG: Complete Heart    |
| 1** | l13h | um |   |        | Block                                |
+-----+------+----+---+--------+--------------------------------------+
| **3 | b    | N  | 8 | YNF.   | Documented by ECG: Other Major       |
| 2** | l13i | um |   |        | Arrhythmias                          |
+-----+------+----+---+--------+--------------------------------------+
| **3 | b    | N  | 8 | YNF.   | Currently Has: Diabetes Mellitus     |
| 5** | l17a | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **3 | b    | N  | 8 | YNF.   | Currently Has: Bronchial Asthma      |
| 6** | l17b | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **3 | b    | N  | 8 | YNF.   | Currently Has: Rheumatic Heart       |
| 7** | l17c | um |   |        | Diseases                             |
+-----+------+----+---+--------+--------------------------------------+
| **3 | b    | N  | 8 | YNF.   | Currently Has: Lower GI Disorder     |
| 8** | l17d | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **3 | b    | N  | 8 | YNF.   | Ever Had: Renal Disease              |
| 9** | l18a | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **4 | b    | N  | 8 | YNF.   | Ever Had: Hepatobiliary Disease      |
| 0** | l18b | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **4 | b    | N  | 8 | YNF.   | Ever Had: Symptomatic Gout           |
| 1** | l18c | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **4 | b    | N  | 8 | YNF.   | Ever Had: Malignant Neoplasia        |
| 2** | l18d | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **7 | bl   | N  | 8 | YNF.   | Used: Other Drugs                    |
| 4** | 33aa | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **7 | bl   | N  | 8 | YNF.   | Used: Diuretics                      |
| 5** | 33bb | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **5 | b    | N  | 8 | YNF.   | Used: Insulin                        |
| 4** | l33g | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **5 | b    | N  | 8 | YNF.   | Used: Oral Hypoglycemic Agents       |
| 5** | l33h | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **5 | b    | N  | 8 | YNF.   | Used: Digitalis                      |
| 6** | l33i | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **5 | b    | N  | 8 | YNF.   | Used: Antiarrhythmic Agents          |
| 7** | l33j | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **5 | b    | N  | 8 | YNF.   | Used: Antihypertensives (not         |
| 8** | l33k | um |   |        | Diuretics)                           |
+-----+------+----+---+--------+--------------------------------------+
| **5 | b    | N  | 8 | YNF.   | Used: Nitroglycerin or Long-Acting   |
| 9** | l33l | um |   |        | Nitrates                             |
+-----+------+----+---+--------+--------------------------------------+
| **6 | b    | N  | 8 | YNF.   | Used: Gout Medication other than     |
| 0** | l33m | um |   |        | Probenecid                           |
+-----+------+----+---+--------+--------------------------------------+
| **6 | b    | N  | 8 | YNF.   | Used: Probenecid                     |
| 1** | l33n | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **6 | b    | N  | 8 | YNF.   | Used: Lipid-Lowering                 |
| 2** | l33o | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **6 | b    | N  | 8 | YNF.   | Used: Phenylbutazone                 |
| 3** | l33p | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **6 | b    | N  | 8 | YNF.   | Used: Indomethacin                   |
| 4** | l33q | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **6 | b    | N  | 8 | YNF.   | Used: Phenothiazines                 |
| 5** | l33r | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **6 | b    | N  | 8 | YNF.   | Used: Tricyclic Antidepressants      |
| 6** | l33s | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **6 | b    | N  | 8 | YNF.   | Used: Antihistamines                 |
| 7** | l33t | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **6 | b    | N  | 8 | YNF.   | Used: Propanolol                     |
| 8** | l33u | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **6 | b    | N  | 8 | YNF.   | Used: Corticosteroid Preparations    |
| 9** | l33v | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **7 | b    | N  | 8 | YNF.   | Used: Tranquilizers                  |
| 0** | l33w | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **7 | b    | N  | 8 | YNF.   | Used: Hypnotics Sedatives,           |
| 1** | l33x | um |   |        | Barbituates                          |
+-----+------+----+---+--------+--------------------------------------+
| **7 | b    | N  | 8 | YNF.   | Used: Vitamins                       |
| 2** | l33y | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **7 | b    | N  | 8 | YNF.   | Used: Estrogens                      |
| 3** | l33z | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | b    | N  | 8 | CL     | Collapsed Value                      |
| *13 | l35c | um |   | LPSEF. |                                      |
| 3** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | b    | N  | 8 | CL     | Collapsed Value                      |
| *13 | l36c | um |   | LPSEF. |                                      |
| 4** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **7 | b    | N  | 8 |        | Systolic Blood Pressure (mm Hg)      |
| 8** | l37a | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | bl   | N  | 8 | CL     | Collapsed Value                      |
| *13 | 37ac | um |   | LPSEF. |                                      |
| 5** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **7 | b    | N  | 8 |        | Diastolic Blood Pressure (mm Hg)     |
| 9** | l37b | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | bl   | N  | 8 | CL     | Collapsed Value                      |
| *13 | 37bc | um |   | LPSEF. |                                      |
| 6** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **8 | b    | N  | 8 | CRTDF. | Peripheral Pulses: Right Carotid     |
| 1** | l42a | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **8 | b    | N  | 8 | CRTDF. | Peripheral Pulses: Left Carotid      |
| 2** | l42b | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **8 | b    | N  | 8 |        | Average SBP (IV1, IV2, B1) (mm Hg)   |
| 3** | l44a | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **8 | b    | N  | 8 |        | Average DBP (IV1, IV2, B1) (mm Hg)   |
| 4** | l44b | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 |        | ECG Data: Heart Rate                 |
| *10 | cg01 | um |   |        |                                      |
| 2** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | QRSF.  | ECG Data: QRS Axis Deviation         |
| *11 | cg06 | um |   |        |                                      |
| 5** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | RWAVF. | ECG Data: High R Wave Amplitude      |
| *11 | cg07 | um |   |        |                                      |
| 6** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | AVF.   | ECG Data: A-V Conduction Defect      |
| *11 | cg08 | um |   |        |                                      |
| 7** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | VENF.  | ECG Data: Ventricular Conduction     |
| *11 | cg09 | um |   |        | Defect                               |
| 8** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | PREMF. | ECG Data: Premature Beats            |
| *11 | cg10 | um |   |        |                                      |
| 9** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | A      | ECG Data: Other Arrhythmias          |
| *12 | cg11 | um |   | RRHYF. |                                      |
| 0** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | S      | ECG Data: Sinus Arrhythmias          |
| *12 | cg12 | um |   | INARF. |                                      |
| 1** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | LO     | ECG Data: Low QRS Amplitude          |
| *12 | cg13 | um |   | WQRSF. |                                      |
| 2** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | PWAVF. | ECG Data: P Wave Amplitude           |
| *12 | cg14 | um |   |        |                                      |
| 3** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | TWAVF. | ECG Data: T Wave Amplitude           |
| *12 | cg15 | um |   |        |                                      |
| 4** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | Q      | ECG Data: QRS Transition             |
| *12 | cg16 | um |   | RSTRF. |                                      |
| 5** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | TECHF. | ECG Data: Technical Problems         |
| *12 | cg17 | um |   |        |                                      |
| 6** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | S      | ECG Data: Supraventricular Beats     |
| *12 | cg18 | um |   | PRBTF. |                                      |
| 7** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | V      | ECG Data: Ventricular Beats          |
| *12 | cg19 | um |   | NTBTF. |                                      |
| 8** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | RNBGF. | ECG Data: Runs and Bigeminy          |
| *12 | cg20 | um |   |        |                                      |
| 9** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | MF     | ECG Data: Multifocal Ectopic Beats   |
| *13 | cg21 | um |   | CLECF. |                                      |
| 0** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | e    | N  | 8 | T      | ECG Data: T-R Interval               |
| *13 | cg22 | um |   | RINTF. |                                      |
| 1** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | ec   | N  | 8 | QS1F.  | ECG Data: Q and QS: Anterolateral    |
| *10 | g02a | um |   |        | Site (leads I, AVL, V6)              |
| 3** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | ec   | N  | 8 | QS2F.  | ECG Data: Q and QS: Posterior        |
| *10 | g02b | um |   |        | (inferior) Site (leads II, III, AVF) |
| 4** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | ec   | N  | 8 | QS3F.  | ECG Data: Q and QS: Anteroseptal     |
| *10 | g02c | um |   |        | Site (leads V1, 2, 3, 4, 5)          |
| 5** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | ec   | N  | 8 | ST1F.  | ECG Data: ST Junction and Segment    |
| *10 | g03a | um |   |        | Depression: Anterolater Site         |
| 6** |      |    |   |        |                                      |
|     |      |    |   |        | (leads I, AVL, V5)                   |
+-----+------+----+---+--------+--------------------------------------+
| *   | ec   | N  | 8 | ST2F.  | ECG Data: ST Junction and Segment    |
| *10 | g03b | um |   |        | Depression: Posterior (inferior)     |
| 7** |      |    |   |        |                                      |
|     |      |    |   |        | Site (leads II, III, AVF)            |
+-----+------+----+---+--------+--------------------------------------+
| *   | ec   | N  | 8 | ST3F.  | ECG Data: ST Junction and Segment    |
| *10 | g03c | um |   |        | Depression: Anteroseptal Site        |
| 8** |      |    |   |        |                                      |
|     |      |    |   |        | (leads V1, 2, 3, 4, 5)               |
+-----+------+----+---+--------+--------------------------------------+
| *   | ec   | N  | 8 | T1F.   | ECG Data: T Items: Anterolateral     |
| *10 | g04a | um |   |        | Site (leads I, AVL, V6)              |
| 9** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | ec   | N  | 8 | T2F.   | ECG Data: T Items: Posterior         |
| *11 | g04b | um |   |        | (inferior) Site (leads II, III, AVF) |
| 0** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | ec   | N  | 8 | T3F.   | ECG Data: T Items: Anteroseptal Site |
| *11 | g04c | um |   |        | (leads V1, 2, 3, 4, 5)               |
| 1** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | ec   | N  | 8 | S      | ECG Data: ST Elevation:              |
| *11 | g05a | um |   | TEL1F. | Anterolateral Site (leads I, AVL,    |
| 2** |      |    |   |        | V6)                                  |
+-----+------+----+---+--------+--------------------------------------+
| *   | ec   | N  | 8 | S      | ECG Data: ST Elevation: Posterior    |
| *11 | g05b | um |   | TEL2F. | (inferior) Site (leads II, III, AVF) |
| 3** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | ec   | N  | 8 | S      | ECG Data: ST Elevation: Anteroseptal |
| *11 | g05c | um |   | TEL3F. | Site (leads V1, 2, 3, 4, 5)          |
| 4** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **  | id   | N  | 8 |        | Patient Identifier                   |
| 1** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **  | iv07 | N  | 8 | SEXF.  | Sex                                  |
| 4** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **  | iv08 | N  | 8 | RACEF. | Race                                 |
| 5** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **  | iv09 | N  | 8 | MAR    | Marital Status                       |
| 6** |      | um |   | STATF. |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **  | iv13 | N  | 8 |        | Age at 1st MI                        |
| 7** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **  | iv16 | N  | 8 |        | No. of MI\'s patient ever had        |
| 9** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **1 | iv50 | N  | 8 |        | White Blood Cell Count (cells/mm3)   |
| 0** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **1 | iv51 | N  | 8 |        | Platelet Count (cells/mm3)           |
| 1** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **  | i    | N  | 8 |        | Yr. uncertain                        |
| 8** | v13a | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | i    | N  | 8 | CL     | Collapsed Value                      |
| *13 | v16c | um |   | LPSEF. |                                      |
| 7** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **1 | i    | N  | 8 | CARDF. | Cardiomegaly                         |
| 2** | v57a | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **1 | i    | N  | 8 | CARDF. | Pleural Effusion                     |
| 3** | v57b | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **1 | i    | N  | 8 | CARDF. | Pulmonary Congestion                 |
| 4** | v57c | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **8 | la05 | N  | 8 |        | Total Bilirubin: Baseline (mg/dl)    |
| 9** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **9 | la09 | N  | 8 |        | SGOT: Baseline                       |
| 0** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **9 | la13 | N  | 8 |        | Cholesterol: Baseline (mg/dl)        |
| 1** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **9 | la17 | N  | 8 |        | Triglyceride: Baseline (mg/dl)       |
| 2** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **9 | la21 | N  | 8 |        | Uric Acid: Baseline (mg/dl)          |
| 3** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **9 | la25 | N  | 8 |        | Alkaline Phosphatase: Baseline       |
| 4** |      | um |   |        | (U/liter)                            |
+-----+------+----+---+--------+--------------------------------------+
| **9 | la29 | N  | 8 |        | Urea: Baseline (mg/dl)               |
| 5** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **9 | la33 | N  | 8 |        | Fasting Glucose: Baseline (mg/dl)    |
| 6** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **9 | la37 | N  | 8 |        | Total Glucose: Baseline (mg/dl)      |
| 7** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **9 | la41 | N  | 8 |        | Potassium: Baseline (mmol/l)         |
| 8** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **9 | la45 | N  | 8 |        | Random Urine: Baseline               |
| 9** |      | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | la49 | N  | 8 |        | Salicylates: Baseline                |
| *10 |      | um |   |        |                                      |
| 0** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| *   | la53 | N  | 8 |        | Platelet Aggregation: Baseline       |
| *10 |      | um |   |        |                                      |
| 1** |      |    |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+
| **  | tr   | N  | 8 | TRTF.  | Treatment Group                      |
| 2** | tgrp | um |   |        |                                      |
+-----+------+----+---+--------+--------------------------------------+

+------+--------+----+----+--------+---------------------------------+
| **V  |        |    |    |        |                                 |
| aria |        |    |    |        |                                 |
| bles |        |    |    |        |                                 |
| in   |        |    |    |        |                                 |
| Crea |        |    |    |        |                                 |
| tion |        |    |    |        |                                 |
| Ord  |        |    |    |        |                                 |
| er** |        |    |    |        |                                 |
+======+========+====+====+========+=================================+
| **Po | **Vari | ** | *  | **Fo   | **Label**                       |
| siti | able** | Ty | *L | rmat** |                                 |
| on** |        | pe | en |        |                                 |
|      |        | ** | ** |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| *    | id     | N  | 8  |        | Patient Identifier              |
| *1** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| *    | trtgrp | N  | 8  | TRTF.  | Treatment Group                 |
| *2** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| *    | age    | N  | 8  |        | Age at Randomization            |
| *3** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| *    | iv07   | N  | 8  | SEXF.  | Sex                             |
| *4** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| *    | iv08   | N  | 8  | RACEF. | Race                            |
| *5** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| *    | iv09   | N  | 8  | MAR    | Marital Status                  |
| *6** |        | um |    | STATF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| *    | iv13   | N  | 8  |        | Age at 1st MI                   |
| *7** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| *    | iv13a  | N  | 8  |        | Yr. uncertain                   |
| *8** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| *    | iv16   | N  | 8  |        | No. of MI\'s patient ever had   |
| *9** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | iv50   | N  | 8  |        | White Blood Cell Count          |
| 10** |        | um |    |        | (cells/mm3)                     |
+------+--------+----+----+--------+---------------------------------+
| **   | iv51   | N  | 8  |        | Platelet Count (cells/mm3)      |
| 11** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | iv57a  | N  | 8  | CARDF. | Cardiomegaly                    |
| 12** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | iv57b  | N  | 8  | CARDF. | Pleural Effusion                |
| 13** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | iv57c  | N  | 8  | CARDF. | Pulmonary Congestion            |
| 14** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl08   | N  | 8  |        | Age at Most Recent MI           |
| 15** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl08a  | N  | 8  |        | Yr. uncertain                   |
| 16** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl10a  | N  | 8  | DNSF.  | Ever Had Stroke                 |
| 17** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl10b  | N  | 8  | DNSF.  | Ever Had Pulmonary Embolism     |
| 18** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl10c  | N  | 8  | DNSF.  | Ever Had Peripheral Arterial    |
| 19** |        | um |    |        | Occlusion                       |
+------+--------+----+----+--------+---------------------------------+
| **   | bl10d  | N  | 8  | DNSF.  | Ever Had Heart Failure          |
| 20** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl10e  | N  | 8  | DNF.   | Ever Had Coronary Arteriography |
| 21** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl11   | N  | 8  | DNSF.  | Experienced Angina Pectoris     |
| 22** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl12   | N  | 8  | NYHAF. | NY Heart Assoc. Class           |
| 23** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl13a  | N  | 8  | YNF.   | Documented by ECG: Atrial       |
| 24** |        | um |    |        | Flutter of Fibrillation         |
+------+--------+----+----+--------+---------------------------------+
| **   | bl13b  | N  | 8  | YNF.   | Documented by ECG: Atrial       |
| 25** |        | um |    |        | Tachycardia                     |
+------+--------+----+----+--------+---------------------------------+
| **   | bl13c  | N  | 8  | YNF.   | Documented by ECG: Functional   |
| 26** |        | um |    |        | Tachycardia                     |
+------+--------+----+----+--------+---------------------------------+
| **   | bl13d  | N  | 8  | YNF.   | Documented by ECG: Ventricular  |
| 27** |        | um |    |        | Tachycardia                     |
+------+--------+----+----+--------+---------------------------------+
| **   | bl13e  | N  | 8  | YNF.   | Documented by ECG: Multifocal   |
| 28** |        | um |    |        | (PVCs)                          |
+------+--------+----+----+--------+---------------------------------+
| **   | bl13f  | N  | 8  | YNF.   | Documented by ECG: Frequent     |
| 29** |        | um |    |        | PVCs                            |
+------+--------+----+----+--------+---------------------------------+
| **   | bl13g  | N  | 8  | YNF.   | Documented by ECG: Second       |
| 30** |        | um |    |        | Degree A-V Block                |
+------+--------+----+----+--------+---------------------------------+
| **   | bl13h  | N  | 8  | YNF.   | Documented by ECG: Complete     |
| 31** |        | um |    |        | Heart Block                     |
+------+--------+----+----+--------+---------------------------------+
| **   | bl13i  | N  | 8  | YNF.   | Documented by ECG: Other Major  |
| 32** |        | um |    |        | Arrhythmias                     |
+------+--------+----+----+--------+---------------------------------+
| **   | bl14   | N  | 8  | YNF.   | Patient Ever Had                |
| 33** |        | um |    |        | Definite/Suspect ICIA?          |
+------+--------+----+----+--------+---------------------------------+
| **   | bl15   | N  | 8  | YNF.   | Patient Ever Had                |
| 34** |        | um |    |        | Definite/Suspect Intermittent   |
|      |        |    |    |        | Claudication?                   |
+------+--------+----+----+--------+---------------------------------+
| **   | bl17a  | N  | 8  | YNF.   | Currently Has: Diabetes         |
| 35** |        | um |    |        | Mellitus                        |
+------+--------+----+----+--------+---------------------------------+
| **   | bl17b  | N  | 8  | YNF.   | Currently Has: Bronchial Asthma |
| 36** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl17c  | N  | 8  | YNF.   | Currently Has: Rheumatic Heart  |
| 37** |        | um |    |        | Diseases                        |
+------+--------+----+----+--------+---------------------------------+
| **   | bl17d  | N  | 8  | YNF.   | Currently Has: Lower GI         |
| 38** |        | um |    |        | Disorder                        |
+------+--------+----+----+--------+---------------------------------+
| **   | bl18a  | N  | 8  | YNF.   | Ever Had: Renal Disease         |
| 39** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl18b  | N  | 8  | YNF.   | Ever Had: Hepatobiliary Disease |
| 40** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl18c  | N  | 8  | YNF.   | Ever Had: Symptomatic Gout      |
| 41** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl18d  | N  | 8  | YNF.   | Ever Had: Malignant Neoplasia   |
| 42** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl19   | N  | 8  | WRKF.  | Work Status                     |
| 43** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl20   | N  | 8  | L      | Life Style                      |
| 44** |        | um |    | FSTLF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl21   | N  | 8  | YNF.   | Patient Ever Forced to Change   |
| 45** |        | um |    |        | Lifestyle                       |
+------+--------+----+----+--------+---------------------------------+
| **   | bl22   | N  | 8  | CFNF.  | Cigarette Smoker                |
| 46** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl23   | N  | 8  | YR     | Years a Smoker                  |
| 47** |        | um |    | SMKRF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl24   | N  | 8  | S      | Average No. Smoked Per Day      |
| 48** |        | um |    | MKPDF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl25   | N  | 8  | CS     | Currently Smoke Per Day         |
| 49** |        | um |    | MKPDF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl26   | N  | 8  |        | Estimated Age Smoking Stopped   |
| 50** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl27   | N  | 8  | CFNF.  | Cigar Smoker                    |
| 51** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl28   | N  | 8  | CFNF.  | Pipe Smoker                     |
| 52** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl30   | N  | 8  | YNF.   | Consumes \> 1.5 oz. Pure Ethyl  |
| 53** |        | um |    |        | Alcohol Per Day                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33g  | N  | 8  | YNF.   | Used: Insulin                   |
| 54** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33h  | N  | 8  | YNF.   | Used: Oral Hypoglycemic Agents  |
| 55** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33i  | N  | 8  | YNF.   | Used: Digitalis                 |
| 56** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33j  | N  | 8  | YNF.   | Used: Antiarrhythmic Agents     |
| 57** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33k  | N  | 8  | YNF.   | Used: Antihypertensives (not    |
| 58** |        | um |    |        | Diuretics)                      |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33l  | N  | 8  | YNF.   | Used: Nitroglycerin or          |
| 59** |        | um |    |        | Long-Acting Nitrates            |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33m  | N  | 8  | YNF.   | Used: Gout Medication other     |
| 60** |        | um |    |        | than Probenecid                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33n  | N  | 8  | YNF.   | Used: Probenecid                |
| 61** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33o  | N  | 8  | YNF.   | Used: Lipid-Lowering            |
| 62** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33p  | N  | 8  | YNF.   | Used: Phenylbutazone            |
| 63** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33q  | N  | 8  | YNF.   | Used: Indomethacin              |
| 64** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33r  | N  | 8  | YNF.   | Used: Phenothiazines            |
| 65** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33s  | N  | 8  | YNF.   | Used: Tricyclic Antidepressants |
| 66** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33t  | N  | 8  | YNF.   | Used: Antihistamines            |
| 67** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33u  | N  | 8  | YNF.   | Used: Propanolol                |
| 68** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33v  | N  | 8  | YNF.   | Used: Corticosteroid            |
| 69** |        | um |    |        | Preparations                    |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33w  | N  | 8  | YNF.   | Used: Tranquilizers             |
| 70** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33x  | N  | 8  | YNF.   | Used: Hypnotics Sedatives,      |
| 71** |        | um |    |        | Barbituates                     |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33y  | N  | 8  | YNF.   | Used: Vitamins                  |
| 72** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33z  | N  | 8  | YNF.   | Used: Estrogens                 |
| 73** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33aa | N  | 8  | YNF.   | Used: Other Drugs               |
| 74** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl33bb | N  | 8  | YNF.   | Used: Diuretics                 |
| 75** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl35   | N  | 8  |        | Height (inches)                 |
| 76** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl36   | N  | 8  |        | Weight (lbs.)                   |
| 77** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl37a  | N  | 8  |        | Systolic Blood Pressure (mm Hg) |
| 78** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl37b  | N  | 8  |        | Diastolic Blood Pressure (mm    |
| 79** |        | um |    |        | Hg)                             |
+------+--------+----+----+--------+---------------------------------+
| **   | bl38   | N  | 8  |        | Pulse Rate: beats per minute    |
| 80** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl42a  | N  | 8  | CRTDF. | Peripheral Pulses: Right        |
| 81** |        | um |    |        | Carotid                         |
+------+--------+----+----+--------+---------------------------------+
| **   | bl42b  | N  | 8  | CRTDF. | Peripheral Pulses: Left Carotid |
| 82** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl44a  | N  | 8  |        | Average SBP (IV1, IV2, B1) (mm  |
| 83** |        | um |    |        | Hg)                             |
+------+--------+----+----+--------+---------------------------------+
| **   | bl44b  | N  | 8  |        | Average DBP (IV1, IV2, B1) (mm  |
| 84** |        | um |    |        | Hg)                             |
+------+--------+----+----+--------+---------------------------------+
| **   | bl49   | N  | 8  |        | Hematocrit (%)                  |
| 85** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl51   | N  | 8  | NPF.   | Hematuria                       |
| 86** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl52   | N  | 8  | NPF.   | Urine Glucose                   |
| 87** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | bl53   | N  | 8  | U      | Urine Protien                   |
| 88** |        | um |    | RPRTF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | la05   | N  | 8  |        | Total Bilirubin: Baseline       |
| 89** |        | um |    |        | (mg/dl)                         |
+------+--------+----+----+--------+---------------------------------+
| **   | la09   | N  | 8  |        | SGOT: Baseline                  |
| 90** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | la13   | N  | 8  |        | Cholesterol: Baseline (mg/dl)   |
| 91** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | la17   | N  | 8  |        | Triglyceride: Baseline (mg/dl)  |
| 92** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | la21   | N  | 8  |        | Uric Acid: Baseline (mg/dl)     |
| 93** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | la25   | N  | 8  |        | Alkaline Phosphatase: Baseline  |
| 94** |        | um |    |        | (U/liter)                       |
+------+--------+----+----+--------+---------------------------------+
| **   | la29   | N  | 8  |        | Urea: Baseline (mg/dl)          |
| 95** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | la33   | N  | 8  |        | Fasting Glucose: Baseline       |
| 96** |        | um |    |        | (mg/dl)                         |
+------+--------+----+----+--------+---------------------------------+
| **   | la37   | N  | 8  |        | Total Glucose: Baseline (mg/dl) |
| 97** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | la41   | N  | 8  |        | Potassium: Baseline (mmol/l)    |
| 98** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **   | la45   | N  | 8  |        | Random Urine: Baseline          |
| 99** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | la49   | N  | 8  |        | Salicylates: Baseline           |
| 00** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | la53   | N  | 8  |        | Platelet Aggregation: Baseline  |
| 01** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg01  | N  | 8  |        | ECG Data: Heart Rate            |
| 02** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg02a | N  | 8  | QS1F.  | ECG Data: Q and QS:             |
| 03** |        | um |    |        | Anterolateral Site (leads I,    |
|      |        |    |    |        | AVL, V6)                        |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg02b | N  | 8  | QS2F.  | ECG Data: Q and QS: Posterior   |
| 04** |        | um |    |        | (inferior) Site (leads II, III, |
|      |        |    |    |        | AVF)                            |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg02c | N  | 8  | QS3F.  | ECG Data: Q and QS:             |
| 05** |        | um |    |        | Anteroseptal Site (leads V1, 2, |
|      |        |    |    |        | 3, 4, 5)                        |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg03a | N  | 8  | ST1F.  | ECG Data: ST Junction and       |
| 06** |        | um |    |        | Segment Depression: Anterolater |
|      |        |    |    |        | Site                            |
|      |        |    |    |        |                                 |
|      |        |    |    |        | (leads I, AVL, V5)              |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg03b | N  | 8  | ST2F.  | ECG Data: ST Junction and       |
| 07** |        | um |    |        | Segment Depression: Posterior   |
|      |        |    |    |        |                                 |
|      |        |    |    |        | (inferior) Site (leads II, III, |
|      |        |    |    |        | AVF)                            |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg03c | N  | 8  | ST3F.  | ECG Data: ST Junction and       |
| 08** |        | um |    |        | Segment Depression:             |
|      |        |    |    |        | Anteroseptal Site               |
|      |        |    |    |        |                                 |
|      |        |    |    |        | (leads V1, 2, 3, 4, 5)          |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg04a | N  | 8  | T1F.   | ECG Data: T Items:              |
| 09** |        | um |    |        | Anterolateral Site (leads I,    |
|      |        |    |    |        | AVL, V6)                        |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg04b | N  | 8  | T2F.   | ECG Data: T Items: Posterior    |
| 10** |        | um |    |        | (inferior) Site (leads II, III, |
|      |        |    |    |        | AVF)                            |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg04c | N  | 8  | T3F.   | ECG Data: T Items: Anteroseptal |
| 11** |        | um |    |        | Site (leads V1, 2, 3, 4, 5)     |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg05a | N  | 8  | S      | ECG Data: ST Elevation:         |
| 12** |        | um |    | TEL1F. | Anterolateral Site (leads I,    |
|      |        |    |    |        | AVL, V6)                        |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg05b | N  | 8  | S      | ECG Data: ST Elevation:         |
| 13** |        | um |    | TEL2F. | Posterior (inferior) Site       |
|      |        |    |    |        | (leads II, III, AVF)            |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg05c | N  | 8  | S      | ECG Data: ST Elevation:         |
| 14** |        | um |    | TEL3F. | Anteroseptal Site (leads V1, 2, |
|      |        |    |    |        | 3, 4, 5)                        |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg06  | N  | 8  | QRSF.  | ECG Data: QRS Axis Deviation    |
| 15** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg07  | N  | 8  | RWAVF. | ECG Data: High R Wave Amplitude |
| 16** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg08  | N  | 8  | AVF.   | ECG Data: A-V Conduction Defect |
| 17** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg09  | N  | 8  | VENF.  | ECG Data: Ventricular           |
| 18** |        | um |    |        | Conduction Defect               |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg10  | N  | 8  | PREMF. | ECG Data: Premature Beats       |
| 19** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg11  | N  | 8  | A      | ECG Data: Other Arrhythmias     |
| 20** |        | um |    | RRHYF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg12  | N  | 8  | S      | ECG Data: Sinus Arrhythmias     |
| 21** |        | um |    | INARF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg13  | N  | 8  | LO     | ECG Data: Low QRS Amplitude     |
| 22** |        | um |    | WQRSF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg14  | N  | 8  | PWAVF. | ECG Data: P Wave Amplitude      |
| 23** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg15  | N  | 8  | TWAVF. | ECG Data: T Wave Amplitude      |
| 24** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg16  | N  | 8  | Q      | ECG Data: QRS Transition        |
| 25** |        | um |    | RSTRF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg17  | N  | 8  | TECHF. | ECG Data: Technical Problems    |
| 26** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg18  | N  | 8  | S      | ECG Data: Supraventricular      |
| 27** |        | um |    | PRBTF. | Beats                           |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg19  | N  | 8  | V      | ECG Data: Ventricular Beats     |
| 28** |        | um |    | NTBTF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg20  | N  | 8  | RNBGF. | ECG Data: Runs and Bigeminy     |
| 29** |        | um |    |        |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg21  | N  | 8  | MF     | ECG Data: Multifocal Ectopic    |
| 30** |        | um |    | CLECF. | Beats                           |
+------+--------+----+----+--------+---------------------------------+
| **1  | ecg22  | N  | 8  | T      | ECG Data: T-R Interval          |
| 31** |        | um |    | RINTF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | agec   | N  | 8  | CL     | Collapsed Value                 |
| 32** |        | um |    | LPSEF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | bl35c  | N  | 8  | CL     | Collapsed Value                 |
| 33** |        | um |    | LPSEF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | bl36c  | N  | 8  | CL     | Collapsed Value                 |
| 34** |        | um |    | LPSEF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | bl37ac | N  | 8  | CL     | Collapsed Value                 |
| 35** |        | um |    | LPSEF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | bl37bc | N  | 8  | CL     | Collapsed Value                 |
| 36** |        | um |    | LPSEF. |                                 |
+------+--------+----+----+--------+---------------------------------+
| **1  | iv16c  | N  | 8  | CL     | Collapsed Value                 |
| 37** |        | um |    | LPSEF. |                                 |
+------+--------+----+----+--------+---------------------------------+

Dataset: Events

Number of Observations: 4524

Number of Variables: 41

Created Date: October 14, 2004

+---+------+---+---+------+---------------------------------------------+
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| A |      |   |   |      |                                             |
| l |      |   |   |      |                                             |
| p |      |   |   |      |                                             |
| h |      |   |   |      |                                             |
| a |      |   |   |      |                                             |
| b |      |   |   |      |                                             |
| e |      |   |   |      |                                             |
| t |      |   |   |      |                                             |
| i |      |   |   |      |                                             |
| c |      |   |   |      |                                             |
| L |      |   |   |      |                                             |
| i |      |   |   |      |                                             |
| s |      |   |   |      |                                             |
| t |      |   |   |      |                                             |
| o |      |   |   |      |                                             |
| f |      |   |   |      |                                             |
| V |      |   |   |      |                                             |
| a |      |   |   |      |                                             |
| r |      |   |   |      |                                             |
| i |      |   |   |      |                                             |
| a |      |   |   |      |                                             |
| b |      |   |   |      |                                             |
| l |      |   |   |      |                                             |
| e |      |   |   |      |                                             |
| s |      |   |   |      |                                             |
| a |      |   |   |      |                                             |
| n |      |   |   |      |                                             |
| d |      |   |   |      |                                             |
| A |      |   |   |      |                                             |
| t |      |   |   |      |                                             |
| t |      |   |   |      |                                             |
| r |      |   |   |      |                                             |
| i |      |   |   |      |                                             |
| b |      |   |   |      |                                             |
| u |      |   |   |      |                                             |
| t |      |   |   |      |                                             |
| e |      |   |   |      |                                             |
| s |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+===+======+===+===+======+=============================================+
| * | **Va | * | * | **   | **Label**                                   |
| * | riab | * | * | Form |                                             |
| \ | le** | T | L | at** |                                             |
| # |      | y | e |      |                                             |
| * |      | p | n |      |                                             |
| * |      | e | * |      |                                             |
|   |      | * | * |      |                                             |
|   |      | * |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | cdi  | C | 2 | \$CO | If Died During Study: Cardiovascular Death: |
| * | imod | h |   | D3F. | Important Immediate                         |
| 6 |      | a |   |      |                                             |
| * |      | r |   |      | Mechanism of Death                          |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | cdii | N | 8 | CLLP | Collapsed Value                             |
| * | modc | u |   | SEF. |                                             |
| 4 |      | m |   |      |                                             |
| 0 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | c    | C | 2 | \$CO | If Died During Study: Cardiovascular Death: |
| * | imod | h |   | D4F. | Contributing Immediate                      |
| 7 |      | a |   |      |                                             |
| * |      | r |   |      | Mechanism of Death                          |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | ci   | N | 8 | CLLP | Collapsed Value                             |
| * | modc | u |   | SEF. |                                             |
| 4 |      | m |   |      |                                             |
| 1 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | c    | C | 2 | \$CO | If Died During Study: Contributing          |
| * | ucod | h |   | D2F. | Underlying Cause of Death                   |
| 5 |      | a |   |      |                                             |
| * |      | r |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | cu   | N | 8 | CLLP | Collapsed Value                             |
| * | codc | u |   | SEF. |                                             |
| 3 |      | m |   |      |                                             |
| 9 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | dn03 | N | 8 |      | If Died During Study: Days in Study to      |
| * |      | u |   |      | Death                                       |
| 3 |      | m |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | id   | N | 8 |      | Patient Identifier                          |
| * |      | u |   |      |                                             |
| 1 |      | m |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | i    | C | 2 | \$CO | If Died During Study: Important Underlying  |
| * | ucod | h |   | D1F. | Cause of Death                              |
| 4 |      | a |   |      |                                             |
| * |      | r |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | iu   | N | 8 | CLLP | Collapsed Value                             |
| * | codc | u |   | SEF. |                                             |
| 3 |      | m |   |      |                                             |
| 8 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf01 | N | 8 | NF   | Angina Pectoris: Event Classification       |
| * |      | u |   | E1F. |                                             |
| 8 |      | m |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf02 | N | 8 |      | Angina Pectoris: Days in Study to Non-fatal |
| * |      | u |   |      | Event                                       |
| 9 |      | m |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf05 | N | 8 | NF   | Cardiovascular Surgery: Procedure           |
| * |      | u |   | E5F. | Classification                              |
| 1 |      | m |   |      |                                             |
| 1 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf06 | N | 8 |      | Cardiovascular Surgery: Days in Study to    |
| * |      | u |   |      | Procedure                                   |
| 1 |      | m |   |      |                                             |
| 2 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf09 | N | 8 | NF   | Coronary Arteriography: Procedure           |
| * |      | u |   | E9F. | Classification                              |
| 1 |      | m |   |      |                                             |
| 4 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf10 | N | 8 |      | Coronary Arteriography: Days in Study to    |
| * |      | u |   |      | Procedure                                   |
| 1 |      | m |   |      |                                             |
| 5 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf13 | N | 8 | NFE  | Heart Failure: Event Classification         |
| * |      | u |   | 13F. |                                             |
| 1 |      | m |   |      |                                             |
| 7 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf14 | N | 8 |      | Heart Failure: Days in Study to Non-fatal   |
| * |      | u |   |      | Event                                       |
| 1 |      | m |   |      |                                             |
| 8 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf17 | N | 8 | NFE  | Intermittent Cerebral Ischemic Attack:      |
| * |      | u |   | 17F. | Event Classification                        |
| 2 |      | m |   |      |                                             |
| 0 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf18 | N | 8 |      | Intermittent Cerebral Ischemic Attack: Days |
| * |      | u |   |      | in Study to Non-fatal Event                 |
| 2 |      | m |   |      |                                             |
| 1 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf21 | N | 8 | NFE  | Intermittent Claudication: Event            |
| * |      | u |   | 21F. | Classification                              |
| 2 |      | m |   |      |                                             |
| 3 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf22 | N | 8 |      | Intermittent Claudication: Days in Study to |
| * |      | u |   |      | Non-fatal Event                             |
| 2 |      | m |   |      |                                             |
| 4 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf25 | N | 8 | NFE  | Myocardial Infarction: Event Classification |
| * |      | u |   | 25F. |                                             |
| 2 |      | m |   |      |                                             |
| 6 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf26 | N | 8 |      | Myocardial Infarction: Days in Study to     |
| * |      | u |   |      | Non-fatal Event                             |
| 2 |      | m |   |      |                                             |
| 7 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf29 | N | 8 | NFE  | Peripheral Arterial Occlusion: Event        |
| * |      | u |   | 29F. | Classification                              |
| 2 |      | m |   |      |                                             |
| 9 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf30 | N | 8 |      | Peripheral Arterial Occlusion: Days in      |
| * |      | u |   |      | Study to Non-fatal Event                    |
| 3 |      | m |   |      |                                             |
| 0 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf33 | N | 8 | NFE  | Pulmonary Embolism: Event Classification    |
| * |      | u |   | 33F. |                                             |
| 3 |      | m |   |      |                                             |
| 2 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf34 | N | 8 |      | Pulmonary Embolism: Days in Study to        |
| * |      | u |   |      | Non-fatal Event                             |
| 3 |      | m |   |      |                                             |
| 3 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf37 | N | 8 | NFE  | Stroke: Event Classification                |
| * |      | u |   | 37F. |                                             |
| 3 |      | m |   |      |                                             |
| 5 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | nf38 | N | 8 |      | Stroke: Days in Study to Non-fatal Event    |
| * |      | u |   |      |                                             |
| 3 |      | m |   |      |                                             |
| 6 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | n    | N | 8 | NF   | Angina Pectoris: Reason For No Days         |
| * | f02i | u |   | E2F. |                                             |
| 1 |      | m |   |      |                                             |
| 0 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | n    | N | 8 | NF   | Cardiovascular Surgery: Reason For No Days  |
| * | f06i | u |   | E6F. |                                             |
| 1 |      | m |   |      |                                             |
| 3 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | n    | N | 8 | NFE  | Coronary Arteriography: Reason For No Days  |
| * | f10i | u |   | 10F. |                                             |
| 1 |      | m |   |      |                                             |
| 6 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | n    | N | 8 | NFE  | Heart Failure: Reason For No Days           |
| * | f14i | u |   | 14F. |                                             |
| 1 |      | m |   |      |                                             |
| 9 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | n    | N | 8 | NFE  | Intermittent Cerebral Ischemic Attack:      |
| * | f18i | u |   | 18F. | Reason For No Days                          |
| 2 |      | m |   |      |                                             |
| 2 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | n    | N | 8 | NFE  | Intermittent Claudication: Reason For No    |
| * | f22i | u |   | 22F. | Days                                        |
| 2 |      | m |   |      |                                             |
| 5 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | n    | N | 8 | NFE  | Myocardial Infarction: Reason For No Days   |
| * | f26i | u |   | 26F. |                                             |
| 2 |      | m |   |      |                                             |
| 8 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | n    | N | 8 | NFE  | Peripheral Arterial Occlusion: Reason For   |
| * | f30i | u |   | 30F. | No Days                                     |
| 3 |      | m |   |      |                                             |
| 1 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | n    | N | 8 | NFE  | Pulmonary Embolism: Reason For No Days      |
| * | f34i | u |   | 34F. |                                             |
| 3 |      | m |   |      |                                             |
| 4 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | n    | N | 8 | NFE  | Stroke: Reason For No Days                  |
| * | f38i | u |   | 38F. |                                             |
| 3 |      | m |   |      |                                             |
| 7 |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+
| * | vit  | N | 8 | VTST | Vital Status                                |
| * | stat | u |   | TSF. |                                             |
| 2 |      | m |   |      |                                             |
| * |      |   |   |      |                                             |
| * |      |   |   |      |                                             |
+---+------+---+---+------+---------------------------------------------+

+-----+------+------+---+-------+-----------------------------------+
| **  |      |      |   |       |                                   |
| Var |      |      |   |       |                                   |
| iab |      |      |   |       |                                   |
| les |      |      |   |       |                                   |
| in  |      |      |   |       |                                   |
| Cr  |      |      |   |       |                                   |
| eat |      |      |   |       |                                   |
| ion |      |      |   |       |                                   |
| O   |      |      |   |       |                                   |
| rde |      |      |   |       |                                   |
| r** |      |      |   |       |                                   |
+=====+======+======+===+=======+===================================+
| **P | **Va | **Ty | * | **For | **Label**                         |
| osi | riab | pe** | * | mat** |                                   |
| tio | le** |      | L |       |                                   |
| n** |      |      | e |       |                                   |
|     |      |      | n |       |                                   |
|     |      |      | * |       |                                   |
|     |      |      | * |       |                                   |
+-----+------+------+---+-------+-----------------------------------+
| **  | id   | Num  | 8 |       | Patient Identifier                |
| 1** |      |      |   |       |                                   |
+-----+------+------+---+-------+-----------------------------------+
| **  | vit  | Num  | 8 | VTS   | Vital Status                      |
| 2** | stat |      |   | TTSF. |                                   |
+-----+------+------+---+-------+-----------------------------------+
| **  | dn03 | Num  | 8 |       | If Died During Study: Days in     |
| 3** |      |      |   |       | Study to Death                    |
+-----+------+------+---+-------+-----------------------------------+
| **  | i    | Char | 2 | \$C   | If Died During Study: Important   |
| 4** | ucod |      |   | OD1F. | Underlying Cause of Death         |
+-----+------+------+---+-------+-----------------------------------+
| **  | c    | Char | 2 | \$C   | If Died During Study:             |
| 5** | ucod |      |   | OD2F. | Contributing Underlying Cause of  |
|     |      |      |   |       | Death                             |
+-----+------+------+---+-------+-----------------------------------+
| **  | cdi  | Char | 2 | \$C   | If Died During Study:             |
| 6** | imod |      |   | OD3F. | Cardiovascular Death: Important   |
|     |      |      |   |       | Immediate                         |
|     |      |      |   |       |                                   |
|     |      |      |   |       | Mechanism of Death                |
+-----+------+------+---+-------+-----------------------------------+
| **  | c    | Char | 2 | \$C   | If Died During Study:             |
| 7** | imod |      |   | OD4F. | Cardiovascular Death:             |
|     |      |      |   |       | Contributing Immediate            |
|     |      |      |   |       |                                   |
|     |      |      |   |       | Mechanism of Death                |
+-----+------+------+---+-------+-----------------------------------+
| **  | nf01 | Num  | 8 | N     | Angina Pectoris: Event            |
| 8** |      |      |   | FE1F. | Classification                    |
+-----+------+------+---+-------+-----------------------------------+
| **  | nf02 | Num  | 8 |       | Angina Pectoris: Days in Study to |
| 9** |      |      |   |       | Non-fatal Event                   |
+-----+------+------+---+-------+-----------------------------------+
| **1 | n    | Num  | 8 | N     | Angina Pectoris: Reason For No    |
| 0** | f02i |      |   | FE2F. | Days                              |
+-----+------+------+---+-------+-----------------------------------+
| **1 | nf05 | Num  | 8 | N     | Cardiovascular Surgery: Procedure |
| 1** |      |      |   | FE5F. | Classification                    |
+-----+------+------+---+-------+-----------------------------------+
| **1 | nf06 | Num  | 8 |       | Cardiovascular Surgery: Days in   |
| 2** |      |      |   |       | Study to Procedure                |
+-----+------+------+---+-------+-----------------------------------+
| **1 | n    | Num  | 8 | N     | Cardiovascular Surgery: Reason    |
| 3** | f06i |      |   | FE6F. | For No Days                       |
+-----+------+------+---+-------+-----------------------------------+
| **1 | nf09 | Num  | 8 | N     | Coronary Arteriography: Procedure |
| 4** |      |      |   | FE9F. | Classification                    |
+-----+------+------+---+-------+-----------------------------------+
| **1 | nf10 | Num  | 8 |       | Coronary Arteriography: Days in   |
| 5** |      |      |   |       | Study to Procedure                |
+-----+------+------+---+-------+-----------------------------------+
| **1 | n    | Num  | 8 | NF    | Coronary Arteriography: Reason    |
| 6** | f10i |      |   | E10F. | For No Days                       |
+-----+------+------+---+-------+-----------------------------------+
| **1 | nf13 | Num  | 8 | NF    | Heart Failure: Event              |
| 7** |      |      |   | E13F. | Classification                    |
+-----+------+------+---+-------+-----------------------------------+
| **1 | nf14 | Num  | 8 |       | Heart Failure: Days in Study to   |
| 8** |      |      |   |       | Non-fatal Event                   |
+-----+------+------+---+-------+-----------------------------------+
| **1 | n    | Num  | 8 | NF    | Heart Failure: Reason For No Days |
| 9** | f14i |      |   | E14F. |                                   |
+-----+------+------+---+-------+-----------------------------------+
| **2 | nf17 | Num  | 8 | NF    | Intermittent Cerebral Ischemic    |
| 0** |      |      |   | E17F. | Attack: Event Classification      |
+-----+------+------+---+-------+-----------------------------------+
| **2 | nf18 | Num  | 8 |       | Intermittent Cerebral Ischemic    |
| 1** |      |      |   |       | Attack: Days in Study to          |
|     |      |      |   |       | Non-fatal Event                   |
+-----+------+------+---+-------+-----------------------------------+
| **2 | n    | Num  | 8 | NF    | Intermittent Cerebral Ischemic    |
| 2** | f18i |      |   | E18F. | Attack: Reason For No Days        |
+-----+------+------+---+-------+-----------------------------------+
| **2 | nf21 | Num  | 8 | NF    | Intermittent Claudication: Event  |
| 3** |      |      |   | E21F. | Classification                    |
+-----+------+------+---+-------+-----------------------------------+
| **2 | nf22 | Num  | 8 |       | Intermittent Claudication: Days   |
| 4** |      |      |   |       | in Study to Non-fatal Event       |
+-----+------+------+---+-------+-----------------------------------+
| **2 | n    | Num  | 8 | NF    | Intermittent Claudication: Reason |
| 5** | f22i |      |   | E22F. | For No Days                       |
+-----+------+------+---+-------+-----------------------------------+
| **2 | nf25 | Num  | 8 | NF    | Myocardial Infarction: Event      |
| 6** |      |      |   | E25F. | Classification                    |
+-----+------+------+---+-------+-----------------------------------+
| **2 | nf26 | Num  | 8 |       | Myocardial Infarction: Days in    |
| 7** |      |      |   |       | Study to Non-fatal Event          |
+-----+------+------+---+-------+-----------------------------------+
| **2 | n    | Num  | 8 | NF    | Myocardial Infarction: Reason For |
| 8** | f26i |      |   | E26F. | No Days                           |
+-----+------+------+---+-------+-----------------------------------+
| **2 | nf29 | Num  | 8 | NF    | Peripheral Arterial Occlusion:    |
| 9** |      |      |   | E29F. | Event Classification              |
+-----+------+------+---+-------+-----------------------------------+
| **3 | nf30 | Num  | 8 |       | Peripheral Arterial Occlusion:    |
| 0** |      |      |   |       | Days in Study to Non-fatal Event  |
+-----+------+------+---+-------+-----------------------------------+
| **3 | n    | Num  | 8 | NF    | Peripheral Arterial Occlusion:    |
| 1** | f30i |      |   | E30F. | Reason For No Days                |
+-----+------+------+---+-------+-----------------------------------+
| **3 | nf33 | Num  | 8 | NF    | Pulmonary Embolism: Event         |
| 2** |      |      |   | E33F. | Classification                    |
+-----+------+------+---+-------+-----------------------------------+
| **3 | nf34 | Num  | 8 |       | Pulmonary Embolism: Days in Study |
| 3** |      |      |   |       | to Non-fatal Event                |
+-----+------+------+---+-------+-----------------------------------+
| **3 | n    | Num  | 8 | NF    | Pulmonary Embolism: Reason For No |
| 4** | f34i |      |   | E34F. | Days                              |
+-----+------+------+---+-------+-----------------------------------+
| **3 | nf37 | Num  | 8 | NF    | Stroke: Event Classification      |
| 5** |      |      |   | E37F. |                                   |
+-----+------+------+---+-------+-----------------------------------+
| **3 | nf38 | Num  | 8 |       | Stroke: Days in Study to          |
| 6** |      |      |   |       | Non-fatal Event                   |
+-----+------+------+---+-------+-----------------------------------+
| **3 | n    | Num  | 8 | NF    | Stroke: Reason For No Days        |
| 7** | f38i |      |   | E38F. |                                   |
+-----+------+------+---+-------+-----------------------------------+
| **3 | iu   | Num  | 8 | CLL   | Collapsed Value                   |
| 8** | codc |      |   | PSEF. |                                   |
+-----+------+------+---+-------+-----------------------------------+
| **3 | cu   | Num  | 8 | CLL   | Collapsed Value                   |
| 9** | codc |      |   | PSEF. |                                   |
+-----+------+------+---+-------+-----------------------------------+
| **4 | cdii | Num  | 8 | CLL   | Collapsed Value                   |
| 0** | modc |      |   | PSEF. |                                   |
+-----+------+------+---+-------+-----------------------------------+
| **4 | ci   | Num  | 8 | CLL   | Collapsed Value                   |
| 1** | modc |      |   | PSEF. |                                   |
+-----+------+------+---+-------+-----------------------------------+

Dataset: Follow-up

Number of Observations: 13572

Number of Variables: 220

Created Date: October 14, 2004

  ----------------------------------------------------------------------------------------------------
  **Alphabetic                                                    
  List of                                                         
  Variables and                                                   
  Attributes**                                                    
  -------------- -------------- ---------- --------- ------------ ------------------------------------
  **Position**   **Variable**   **Type**   **Len**   **Format**   **Label**

  **46**         fv03           Num        8                      Days in Study to Visit

  **47**         fv09           Num        8         WRKF.        Work Status

  **73**         fv17           Num        8         YNF.         Hospitalized Since Last Study Visit

  **74**         fv18           Num        8         NYHA1F.      NY Heart Assoc. Classification

  **75**         fv19           Num        8         LFSTLF.      Current Life Style

  **76**         fv20           Num        8         INCDECF.     Patient\'s Degree of Physical
                                                                  Activity Since Last Reported Visit

  **77**         fv21           Num        8         CSMKPDF.     No. of Cigarettes Currently smokes
                                                                  per Day

  **111**        fv25           Num        8         YNF.         Was a Compound Containing Salicylate
                                                                  Derivatives Used in the Last Week

  **116**        fv27           Num        8         STDMEDF.     Since Last Study Visit Has Patient
                                                                  Reported Problems Related to Study
                                                                  Medication

  **138**        fv31           Num        8                      Total Number of Capsules Prescribed
                                                                  Since Last Study Visit

  **139**        fv32           Num        8                      Total Number of Capsules Taken Since
                                                                  Last Study Visit

  **140**        fv33           Num        8         MEDSF.       Did patient Take Number of Capsules
                                                                  Prescribed?

  **160**        fv35           Num        8         YNF.         Has Sealed Medication Code Been
                                                                  Broken

  **161**        fv36           Num        8                      Weight (lbs.)

  **164**        fv38           Num        8                      Pulse Rate (beats per minute)

  **165**        fv39           Num        8         YNF.         Rhythm Regular

  **175**        fv45           Num        8         HRSBETF.     Hours Between Drug Dose and
                                                                  Collection of Urine Specimen

  **176**        fv46           Num        8         NPF.         Hematuria

  **177**        fv47           Num        8         NPF.         Urine Glucose

  **178**        fv48           Num        8                      Urine Protein

  **179**        fv50           Num        8         YNF.         Patient Scheduled for Interim Urine
                                                                  Salicylate Determination

  **183**        fv52           Num        8                      Hematocrit (%)

  **184**        fv53           Num        8         YNF.         Platelet Aggregation Test Performed

  **185**        fv54           Num        8                      Platelet Count (cells/mm3)

  **193**        fv57           Num        8         YNF.         Physician\'s Opinion: Does
                                                                  Coagulation Profile Containdicate
                                                                  Patient\'s Continued Prescription of
                                                                  Study Medication

  **194**        fv58           Num        8                      White Blood Cell Count (cells/mm3)

  **48**         fv11i          Num        8         ANGNA1F.     Diagnosed or Performed: Angina or
                                                                  Non-MI Chest Pain: Patient Ever
                                                                  Reported AP on Any Study Form (rev.
                                                                  1)

  **49**         fv11ii         Num        8         ANGNA2F.     Diagnosed or Performed: Angina or
                                                                  Non-MI Chest Pain: Has Patient
                                                                  Experienced AP or Non-MI Chest Pain
                                                                  Since Last Completed Study Visit
                                                                  (rev. 2)

  **50**         fv12a          Num        8         YNF.         Diagnosed & Documented by ECG:
                                                                  Atrial Flutter of Fibrillation

  **51**         fv12b          Num        8         YNF.         Diagnosed & Documented by ECG:
                                                                  Atrial Tachycardia

  **52**         fv12c          Num        8         YNF.         Diagnosed & Documented by ECG:
                                                                  Junctional Tachycardia

  **53**         fv12d          Num        8         YNF.         Diagnosed & Documented by ECG:
                                                                  Ventricular Tachycardia

  **54**         fv12e          Num        8         YNF.         Diagnosed & Documented by ECG:
                                                                  Multifocal (PVCs)

  **55**         fv12f          Num        8         YNF.         Diagnosed & Documented by ECG:
                                                                  Frequent PVCs

  **56**         fv12g          Num        8         YNF.         Diagnosed & Documented by ECG:
                                                                  Second Degree A-V Block

  **57**         fv12h          Num        8         YNF.         Diagnosed & Documented by ECG:
                                                                  Complete Heart Block

  **58**         fv12i          Num        8         YNF.         Diagnosed & Documented by ECG: Other
                                                                  Major Arrhythmias

  **59**         fv13i          Num        8         ANGNA1F.     Intermittent Cerebral Ischemic
                                                                  Attacks Diagnosed: Has Patient Ever
                                                                  Reported ICIA on Any Study Form
                                                                  (rev. 1)

  **62**         fv13ii         Num        8         YNF.         Intermittent Cerebral Ischemic
                                                                  Attacks Diagnosed: Has Patient
                                                                  Experienced ICIA Since Last
                                                                  Completed Study Visit (rev. 2)

  **60**         fv14i          Num        8         ANGNA1F.     Intermittent Claudication Diagnosed:
                                                                  Has Patient Ever Reported IC on Any
                                                                  Study Form (rev. 1)

  **63**         fv14ii         Num        8         YNF.         Intermittent Claudication Diagnosed:
                                                                  Has Patient Experienced IC Since
                                                                  Last Completed Study Visit (rev. 2)

  **65**         fv15a          Num        8         DSNAF.       Heart Failure Diagnosed: Condition
                                                                  diagnosed as

  **61**         fv15i          Num        8         ANGNA1F.     Heart Failure Diagnosed: Has Patient
                                                                  Ever Reported Heart Failure on Any
                                                                  Study Form (rev. 1)

  **64**         fv15ii         Num        8         YNF.         Heart Failure Diagnosed: Has Patient
                                                                  Experienced Heart Failure Since Last
                                                                  Completed Study Visit (rev. 2)

  **66**         fv16a          Num        8         YNF.         Diagnosed Since Last Visit: Diabetes
                                                                  Mellitus

  **67**         fv16b          Num        8         YNF.         Diagnosed Since Last Visit:
                                                                  Bronchial Asthma

  **68**         fv16c          Num        8         YNF.         Diagnosed Since Last Visit: Lower GI
                                                                  Disorder

  **69**         fv16d          Num        8         YNF.         Diagnosed Since Last Visit: Renal
                                                                  Disorder

  **70**         fv16e          Num        8         YNF.         Diagnosed Since Last Visit:
                                                                  Hepatobiliary Disease

  **71**         fv16f          Num        8         YNF.         Diagnosed Since Last Visit:
                                                                  Symptomatic Gout

  **72**         fv16g          Num        8         YNF.         Diagnosed Since Last Visit:
                                                                  Malignant Neoplasia

  **78**         fv22a          Num        8         YNF.         Currently Smokes a Pipe

  **79**         fv22b          Num        8         YNF.         Currently Smokes Cigars

  **80**         fv23a          Num        8         YNF.         Used Since Last Study Visit: Oral
                                                                  Anticoagulants

  **81**         fv23b          Num        8         YNF.         Used Since Last Study Visit: Heparin

  **82**         fv23c          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Dipyridamole

  **83**         fv23d          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Sulfinpyrazone

  **84**         fv23e          Num        8         YNF.         Used Since Last Study Visit: Aspirin

  **85**         fv23f          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Aspirin-containing Medications

  **86**         fv24a          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Antacids

  **87**         fv24b          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Anticholinergics

  **88**         fv24c          Num        8         YNF.         Used Since Last Study Visit: Insulin

  **89**         fv24d          Num        8         YNF.         Used Since Last Study Visit: Oral
                                                                  Hypoglycemic Agents

  **90**         fv24e          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Digitalis

  **91**         fv24f          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Antiarrhythmic Agents

  **92**         fv24g          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Antihypertensives other than
                                                                  Diuretics

  **93**         fv24h          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Nitroglycerin or Long-acting
                                                                  Nitrates

  **94**         fv24i          Num        8         YNF.         Used Since Last Study Visit: Gout
                                                                  Medication Other Than Probenecid

  **95**         fv24j          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Probenecid

  **96**         fv24k          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Lipid-lowering drugs

  **97**         fv24l          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Phenylbutazone

  **98**         fv24m          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Indomethacin

  **99**         fv24n          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Phenothiazines

  **100**        fv24o          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Tricyclic Antidepressants

  **101**        fv24p          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Antihistamines

  **102**        fv24q          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Propanolol

  **103**        fv24r          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Corticosteroid

  **104**        fv24s          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Tranquilizers

  **105**        fv24t          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Hypnotics, Sedatives, Barbituates

  **106**        fv24u          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Vitamins

  **107**        fv24v          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Estrogens

  **108**        fv24w          Num        8         YNF.         Used Since Last Study Visit: Other
                                                                  Drugs

  **109**        fv24x          Num        8         YNF.         Used Since Last Study Visit:
                                                                  Diuretics

  **110**        fv24x1         Num        8         DIURF.       If Used Diuretics, Why?

  **112**        fv26a          Num        8         YNF.         Patient Used Drugs Supplied by
                                                                  Clinic: Acetaminophen

  **113**        fv26a1         Num        8                      No. of Capsules of Acetaminophen
                                                                  Since Last Visit

  **114**        fv26b          Num        8         YNF.         Patient Used Drugs Supplied by
                                                                  Clinic: Propoxyphene Hydrochloride

  **115**        fv26b2         Num        8                      No. of Capsules of Propoxyphene
                                                                  Hydrochloride Since Last Visit

  **117**        fv27a          Num        8         YNF.         Patient Reported: Difficulty
                                                                  Swallowing Capsules

  **118**        fv27b          Num        8         YNF.         Patient Reported: Heartburn

  **119**        fv27c          Num        8         YNF.         Patient Reported: Stomach Pain

  **120**        fv27d          Num        8         YNF.         Patient Reported: Nausea w/o
                                                                  vomitting

  **121**        fv27e          Num        8         YNF.         Patient Reported: Vomitting

  **122**        fv27f          Num        8         YNF.         Patient Reported: Hematemesis

  **123**        fv27g          Num        8         YNF.         Patient Reported: Constipation

  **124**        fv27h          Num        8         YNF.         Patient Reported: Diarrhea

  **125**        fv27i          Num        8         YNF.         Patient Reported: Black Tarry Stools

  **126**        fv27j          Num        8         YNF.         Patient Reported: Bloody Stool

  **127**        fv27k          Num        8         YNF.         Patient Reported: Urticaria

  **128**        fv27l          Num        8         YNF.         Patient Reported: Other Types of
                                                                  Rash

  **129**        fv27m          Num        8         YNF.         Patient Reported: Dizziness

  **130**        fv27n          Num        8         YNF.         Patient Reported: Development or
                                                                  Worsening of Bronchial Asthma

  **131**        fv27o          Num        8         YNF.         Patient Reported: Other Problems

  **132**        fv28a          Num        8         YNF.         Patient Has Experienced Since Last
                                                                  Study Visit (Prompted by Examiner):
                                                                  Symptoms Suggestive of Peptic Ulcer,
                                                                  Gastritis or Erosion of Gastric
                                                                  Mucosa

  **133**        fv28b          Num        8         YNF.         Patient Has Experienced Since Last
                                                                  Study Visit (Prompted by Examiner):
                                                                  Hematemesis

  **134**        fv28c          Num        8         YNF.         Patient Has Experienced Since Last
                                                                  Study Visit (Prompted by Examiner):
                                                                  Black Tarry Stools

  **135**        fv28d          Num        8         YNF.         Patient Has Experienced Since Last
                                                                  Study Visit (Prompted by Examiner):
                                                                  Bloody Stools

  **136**        fv29e          Num        8         YNF.         Prescription Changes Made in
                                                                  Medication?

  **137**        fv30a          Num        8         REDPREF.     Reason For Reduced Prescription:
                                                                  Main Reason

  **141**        fv33a          Num        8         MRNAF.       If No, Main Reason Was:
                                                                  Forgetfullness or Other Non-medical
                                                                  Reason

  **142**        fv33b          Num        8         MRNAF.       If No, Main Reason Was:
                                                                  Unwillingness/Refusal to Take
                                                                  Prescribed Medication

  **143**        fv33c          Num        8         MRNAF.       If No, Main Reason Was: Difficulty
                                                                  in Swallowing Capsules

  **144**        fv33d          Num        8         MRNAF.       If No, Main Reason Was: Heartburn

  **145**        fv33e          Num        8         MRNAF.       If No, Main Reason Was: Stomach Pain

  **146**        fv33f          Num        8         MRNAF.       If No, Main Reason Was: Nausea w/o
                                                                  Vomitting

  **147**        fv33g          Num        8         MRNAF.       If No, Main Reason Was: Vomitting

  **148**        fv33h          Num        8         MRNAF.       If No, Main Reason Was: Hematemesis

  **149**        fv33i          Num        8         MRNAF.       If No, Main Reason Was: Constipation

  **150**        fv33j          Num        8         MRNAF.       If No, Main Reason Was: Diarrhea

  **151**        fv33k          Num        8         MRNAF.       If No, Main Reason Was: Back Tarry
                                                                  Stools

  **152**        fv33l          Num        8         MRNAF.       If No, Main Reason Was: Bloody
                                                                  Stools

  **153**        fv33m          Num        8         MRNAF.       If No, Main Reason Was: Urticaria

  **154**        fv33n          Num        8         MRNAF.       If No, Main Reason Was: Other Types
                                                                  of Rash

  **155**        fv33o          Num        8         MRNAF.       If No, Main Reason Was: Dizziness

  **156**        fv33p          Num        8         MRNAF.       If No, Main Reason Was: Development
                                                                  or Worsenning of Bronchial Asthma

  **157**        fv33q          Num        8         MRNAF.       If No, Main Reason Was: Unable to
                                                                  Determine Reason

  **158**        fv33r          Num        8         MRNAF.       If No, Main Reason Was: Other
                                                                  Problems

  **159**        fv34a          Num        8         YESF.        No Study Medication or Single-blind
                                                                  Placebo Prescribed

  **218**        fv36c          Num        8         CLLPSEF.     Collapsed Value

  **162**        fv37a          Num        8                      SBP (mm Hg)

  **219**        fv37ac         Num        8         CLLPSEF.     Collapsed Value

  **163**        fv37b          Num        8                      DBP (mm Hg)

  **220**        fv37bc         Num        8         CLLPSEF.     Collapsed Value

  **166**        fv40a          Num        8         YNF.         Findings Present: Peripheral Edema

  **167**        fv40b          Num        8         YNF.         Findings Present: Ventricular
                                                                  Diastolic Gallop

  **168**        fv40c          Num        8         YNF.         Findings Present: Basilar Rales

  **169**        fv41a          Num        8         YNF.         Findings Present: Epigastric
                                                                  Tenderness

  **170**        fv41b          Num        8         YNF.         Findings Present: Hepatomegaly

  **171**        fv41c          Num        8         YNF.         Findings Present: Splenomegaly

  **172**        fv44b          Num        8                      Time Urine Specimen Collected: Hour

  **173**        fv44c          Num        8                      Time Urine Specimen Collected:
                                                                  Minutes

  **174**        fv44d          Num        8         AMPMF.       Time Urine Specimen Collected: AM/PM

  **180**        fv51b          Num        8                      Time: Hour

  **181**        fv51c          Num        8                      Time: Minutes

  **182**        fv51d          Num        8         AMPMF.       Time: AM/PM

  **186**        fv55a1         Num        8                      Prothrombin Activity: Patient\'s
                                                                  Value: Seconds

  **187**        fv55a2         Num        8                      Prothrombin Activity: Patient\'s
                                                                  Value: Percent

  **188**        fv55b1         Num        8                      Prothrombin Activity: Normal
                                                                  (Control) Value: Seconds

  **189**        fv55b2         Num        8                      Prothrombin Activity: Normal
                                                                  (Control) Value: Percent

  **190**        fv56a          Num        8                      Partial Thromboplastin: Time:
                                                                  Patient\'s Value: Seconds

  **191**        fv56b1         Num        8                      Partial Thromboplastin: Time: Normal
                                                                  (Control) Value: From (in seconds)

  **192**        fv56b2         Num        8                      Partial Thromboplastin: Time: Normal
                                                                  (Control) Value: To (in seconds)

  **195**        fv61a          Num        8         DNPNAF.      Chest X-ray: Cardiomegaly

  **196**        fv61b          Num        8         DNPNAF.      Chest X-ray: Pleural Effusion

  **197**        fv61c          Num        8         DNPNAF.      Chest X-ray: Pulmonary Congestion

  **45**         fvrev          Num        8                      Follow-up Form Revision

  **1**          id             Num        8                      Patient Identifier

  **2**          invex1         Num        8         INVF.        Follow-up Visit Form: Visit 1

  **3**          invex2         Num        8         INVF.        Follow-up Visit Form: Visit 2

  **4**          invex3         Num        8         INVF.        Follow-up Visit Form: Visit 3

  **5**          la06           Num        8                      Total Bilirubin: Exam 4 (mg/dl)

  **6**          la07           Num        8                      Total Bilirubin: Exam 7 (mg/dl)

  **7**          la08           Num        8                      Total Bilirubin: Exam 10 (mg/dl)

  **8**          la10           Num        8                      SGOT: Exam 4

  **9**          la11           Num        8                      SGOT: Exam 7

  **10**         la12           Num        8                      SGOT: Exam 10

  **11**         la14           Num        8                      Cholesterol: Exam 4 (mg/dl)

  **12**         la15           Num        8                      Cholesterol: Exam 7 (mg/dl)

  **13**         la16           Num        8                      Cholesterol: Exam 10 (mg/dl)

  **14**         la18           Num        8                      Triglyceride: Exam 4 (mg/dl)

  **15**         la19           Num        8                      Triglyceride: Exam 7 (mg/dl)

  **16**         la20           Num        8                      Triglyceride: Exam 10 (mg/dl)

  **17**         la22           Num        8                      Uric Acid: Exam 4 (mg/dl)

  **18**         la23           Num        8                      Uric Acid: Exam 7 (mg/dl)

  **19**         la24           Num        8                      Uric Acid: Exam 10 (mg/dl)

  **20**         la26           Num        8                      Alkaline Phosphatase: Exam 4
                                                                  (U/liter)

  **21**         la27           Num        8                      Alkaline Phosphatase: Exam 7
                                                                  (U/liter)

  **22**         la28           Num        8                      Alkaline Phosphatase: Exam 10
                                                                  (U/liter)

  **23**         la30           Num        8                      Urea: Exam 4 (mg/dl)

  **24**         la31           Num        8                      Urea: Exam 7 (mg/dl)

  **25**         la32           Num        8                      Urea: Exam 10 (mg/dl)

  **26**         la34           Num        8                      Fasting Glucose: Exam 4 (mg/dl)

  **27**         la35           Num        8                      Fasting Glucose: Exam 7 (mg/dl)

  **28**         la36           Num        8                      Fasting Glucose: Exam 10 (mg/dl)

  **29**         la38           Num        8                      Total Glucose: Exam 4 (mg/dl)

  **30**         la39           Num        8                      Total Glucose: Exam 7 (mg/dl)

  **31**         la40           Num        8                      Total Glucose: Exam 10 (mg/dl)

  **32**         la42           Num        8                      Potassium: Exam 4 (mmol/l)

  **33**         la43           Num        8                      Potassium: Exam 7 (mmol/l)

  **34**         la44           Num        8                      Potassium: Exam 10 (mmol/l)

  **35**         la46           Num        8                      Random Urine: Exam 4

  **36**         la47           Num        8                      Random Urine: Exam 7

  **37**         la48           Num        8                      Random Urine: Exam 10

  **38**         la50           Num        8                      Salicylates: Exam 4

  **39**         la51           Num        8                      Salicylates: Exam 7

  **40**         la52           Num        8                      Salicylates: Exam 10

  **41**         la54           Num        8                      Platelet Aggregation: Exam 4

  **42**         la55           Num        8                      Platelet Aggregation: Exam 7

  **43**         la56           Num        8                      Platelet Aggregation: Exam 10

  **211**        mv09           Num        8         YNF.         Patient Hospitalized Since Last
                                                                  Visit

  **212**        mv10           Num        8         YNF.         Study Medication Discontinued

  **199**        mv08a          Num        8         NSPDF.       Events or Procedures Performed:
                                                                  Myocardial Infarction

  **200**        mv08b          Num        8         NDF.         Events or Procedures Performed:
                                                                  Angina Pectoris or Other Chest Pain
                                                                  Related to Ischemic Heart Disease
                                                                  Requiring Hospitalization

  **201**        mv08c          Num        8         NDF.         Events or Procedures Performed:
                                                                  Angina Pectoris Not Requiring
                                                                  Hospitalization

  **202**        mv08d          Num        8         NSPDF.       Events or Procedures Performed:
                                                                  Stroke

  **203**        mv08e          Num        8         NSPDF.       Events or Procedures Performed:
                                                                  Intermittent Cerebral Aschemic
                                                                  Attack

  **204**        mv08f          Num        8         NSPDF.       Events or Procedures Performed:
                                                                  Peripheral Arterial Occlusion

  **205**        mv08g          Num        8         NSPDF.       Events or Procedures Performed:
                                                                  Intermittent Claudication

  **206**        mv08h          Num        8         NSPDF.       Events or Procedures Performed:
                                                                  Pulmonary Embolism

  **207**        mv08i          Num        8         NDF.         Events or Procedures Performed:
                                                                  Cardiovascular Surgery

  **208**        mv08j          Num        8         NDF.         Events or Procedures Performed:
                                                                  Gastrointestinal Disorder

  **209**        mv08k          Num        8         NDF.         Events or Procedures Performed:
                                                                  Coronary Arteriography

  **210**        mv08l          Num        8         NSDUNAF.     Events or Procedures Performed:
                                                                  Heart Failure

  **213**        mv10b          Num        8         DISCONF.     Reason For Discontinuation: Main
                                                                  Reason

  **214**        mv10c          Num        8         DISCONF.     Reason For Discontinuation:
                                                                  Additional Reason 1

  **215**        mv10d          Num        8         DISCONF.     Reason For Discontinuation:
                                                                  Additional Reason 2

  **216**        mv10e          Num        8         DISCONF.     Reason For Discontinuation:
                                                                  Additional Reason 3

  **217**        mv10f          Num        8         DISCONF.     Reason For Discontinuation:
                                                                  Additional Reason 4

  **198**        mvrev          Num        8                      Missed Visit Form Revision

  **44**         visit          Num        8                      Visit No.
  ----------------------------------------------------------------------------------------------------

+------+--------+----+----+--------+-----------------------------------+
| **V  |        |    |    |        |                                   |
| aria |        |    |    |        |                                   |
| bles |        |    |    |        |                                   |
| in   |        |    |    |        |                                   |
| Crea |        |    |    |        |                                   |
| tion |        |    |    |        |                                   |
| Ord  |        |    |    |        |                                   |
| er** |        |    |    |        |                                   |
+======+========+====+====+========+===================================+
| **Po | **Vari | ** | *  | **Fo   | **Label**                         |
| siti | able** | Ty | *L | rmat** |                                   |
| on** |        | pe | en |        |                                   |
|      |        | ** | ** |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| *    | id     | N  | 8  |        | Patient Identifier                |
| *1** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| *    | invex1 | N  | 8  | INVF.  | Follow-up Visit Form: Visit 1     |
| *2** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| *    | invex2 | N  | 8  | INVF.  | Follow-up Visit Form: Visit 2     |
| *3** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| *    | invex3 | N  | 8  | INVF.  | Follow-up Visit Form: Visit 3     |
| *4** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| *    | la06   | N  | 8  |        | Total Bilirubin: Exam 4 (mg/dl)   |
| *5** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| *    | la07   | N  | 8  |        | Total Bilirubin: Exam 7 (mg/dl)   |
| *6** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| *    | la08   | N  | 8  |        | Total Bilirubin: Exam 10 (mg/dl)  |
| *7** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| *    | la10   | N  | 8  |        | SGOT: Exam 4                      |
| *8** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| *    | la11   | N  | 8  |        | SGOT: Exam 7                      |
| *9** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la12   | N  | 8  |        | SGOT: Exam 10                     |
| 10** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la14   | N  | 8  |        | Cholesterol: Exam 4 (mg/dl)       |
| 11** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la15   | N  | 8  |        | Cholesterol: Exam 7 (mg/dl)       |
| 12** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la16   | N  | 8  |        | Cholesterol: Exam 10 (mg/dl)      |
| 13** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la18   | N  | 8  |        | Triglyceride: Exam 4 (mg/dl)      |
| 14** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la19   | N  | 8  |        | Triglyceride: Exam 7 (mg/dl)      |
| 15** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la20   | N  | 8  |        | Triglyceride: Exam 10 (mg/dl)     |
| 16** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la22   | N  | 8  |        | Uric Acid: Exam 4 (mg/dl)         |
| 17** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la23   | N  | 8  |        | Uric Acid: Exam 7 (mg/dl)         |
| 18** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la24   | N  | 8  |        | Uric Acid: Exam 10 (mg/dl)        |
| 19** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la26   | N  | 8  |        | Alkaline Phosphatase: Exam 4      |
| 20** |        | um |    |        | (U/liter)                         |
+------+--------+----+----+--------+-----------------------------------+
| **   | la27   | N  | 8  |        | Alkaline Phosphatase: Exam 7      |
| 21** |        | um |    |        | (U/liter)                         |
+------+--------+----+----+--------+-----------------------------------+
| **   | la28   | N  | 8  |        | Alkaline Phosphatase: Exam 10     |
| 22** |        | um |    |        | (U/liter)                         |
+------+--------+----+----+--------+-----------------------------------+
| **   | la30   | N  | 8  |        | Urea: Exam 4 (mg/dl)              |
| 23** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la31   | N  | 8  |        | Urea: Exam 7 (mg/dl)              |
| 24** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la32   | N  | 8  |        | Urea: Exam 10 (mg/dl)             |
| 25** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la34   | N  | 8  |        | Fasting Glucose: Exam 4 (mg/dl)   |
| 26** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la35   | N  | 8  |        | Fasting Glucose: Exam 7 (mg/dl)   |
| 27** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la36   | N  | 8  |        | Fasting Glucose: Exam 10 (mg/dl)  |
| 28** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la38   | N  | 8  |        | Total Glucose: Exam 4 (mg/dl)     |
| 29** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la39   | N  | 8  |        | Total Glucose: Exam 7 (mg/dl)     |
| 30** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la40   | N  | 8  |        | Total Glucose: Exam 10 (mg/dl)    |
| 31** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la42   | N  | 8  |        | Potassium: Exam 4 (mmol/l)        |
| 32** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la43   | N  | 8  |        | Potassium: Exam 7 (mmol/l)        |
| 33** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la44   | N  | 8  |        | Potassium: Exam 10 (mmol/l)       |
| 34** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la46   | N  | 8  |        | Random Urine: Exam 4              |
| 35** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la47   | N  | 8  |        | Random Urine: Exam 7              |
| 36** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la48   | N  | 8  |        | Random Urine: Exam 10             |
| 37** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la50   | N  | 8  |        | Salicylates: Exam 4               |
| 38** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la51   | N  | 8  |        | Salicylates: Exam 7               |
| 39** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la52   | N  | 8  |        | Salicylates: Exam 10              |
| 40** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la54   | N  | 8  |        | Platelet Aggregation: Exam 4      |
| 41** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la55   | N  | 8  |        | Platelet Aggregation: Exam 7      |
| 42** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | la56   | N  | 8  |        | Platelet Aggregation: Exam 10     |
| 43** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | visit  | N  | 8  |        | Visit No.                         |
| 44** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | fvrev  | N  | 8  |        | Follow-up Form Revision           |
| 45** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv03   | N  | 8  |        | Days in Study to Visit            |
| 46** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv09   | N  | 8  | WRKF.  | Work Status                       |
| 47** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv11i  | N  | 8  | AN     | Diagnosed or Performed: Angina or |
| 48** |        | um |    | GNA1F. | Non-MI Chest Pain: Patient Ever   |
|      |        |    |    |        | Reported AP on Any Study Form     |
|      |        |    |    |        | (rev. 1)                          |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv11ii | N  | 8  | AN     | Diagnosed or Performed: Angina or |
| 49** |        | um |    | GNA2F. | Non-MI Chest Pain: Has Patient    |
|      |        |    |    |        | Experienced AP or Non-MI Chest    |
|      |        |    |    |        | Pain Since Last Completed Study   |
|      |        |    |    |        | Visit (rev. 2)                    |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv12a  | N  | 8  | YNF.   | Diagnosed & Documented by ECG:    |
| 50** |        | um |    |        | Atrial Flutter of Fibrillation    |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv12b  | N  | 8  | YNF.   | Diagnosed & Documented by ECG:    |
| 51** |        | um |    |        | Atrial Tachycardia                |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv12c  | N  | 8  | YNF.   | Diagnosed & Documented by ECG:    |
| 52** |        | um |    |        | Junctional Tachycardia            |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv12d  | N  | 8  | YNF.   | Diagnosed & Documented by ECG:    |
| 53** |        | um |    |        | Ventricular Tachycardia           |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv12e  | N  | 8  | YNF.   | Diagnosed & Documented by ECG:    |
| 54** |        | um |    |        | Multifocal (PVCs)                 |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv12f  | N  | 8  | YNF.   | Diagnosed & Documented by ECG:    |
| 55** |        | um |    |        | Frequent PVCs                     |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv12g  | N  | 8  | YNF.   | Diagnosed & Documented by ECG:    |
| 56** |        | um |    |        | Second Degree A-V Block           |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv12h  | N  | 8  | YNF.   | Diagnosed & Documented by ECG:    |
| 57** |        | um |    |        | Complete Heart Block              |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv12i  | N  | 8  | YNF.   | Diagnosed & Documented by ECG:    |
| 58** |        | um |    |        | Other Major Arrhythmias           |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv13i  | N  | 8  | AN     | Intermittent Cerebral Ischemic    |
| 59** |        | um |    | GNA1F. | Attacks Diagnosed: Has Patient    |
|      |        |    |    |        | Ever Reported ICIA on Any Study   |
|      |        |    |    |        | Form (rev. 1)                     |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv14i  | N  | 8  | AN     | Intermittent Claudication         |
| 60** |        | um |    | GNA1F. | Diagnosed: Has Patient Ever       |
|      |        |    |    |        | Reported IC on Any Study Form     |
|      |        |    |    |        | (rev. 1)                          |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv15i  | N  | 8  | AN     | Heart Failure Diagnosed: Has      |
| 61** |        | um |    | GNA1F. | Patient Ever Reported Heart       |
|      |        |    |    |        | Failure on Any Study Form (rev.   |
|      |        |    |    |        | 1)                                |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv13ii | N  | 8  | YNF.   | Intermittent Cerebral Ischemic    |
| 62** |        | um |    |        | Attacks Diagnosed: Has Patient    |
|      |        |    |    |        | Experienced ICIA Since Last       |
|      |        |    |    |        | Completed Study Visit (rev. 2)    |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv14ii | N  | 8  | YNF.   | Intermittent Claudication         |
| 63** |        | um |    |        | Diagnosed: Has Patient            |
|      |        |    |    |        | Experienced IC Since Last         |
|      |        |    |    |        | Completed Study Visit (rev. 2)    |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv15ii | N  | 8  | YNF.   | Heart Failure Diagnosed: Has      |
| 64** |        | um |    |        | Patient Experienced Heart Failure |
|      |        |    |    |        | Since Last Completed Study Visit  |
|      |        |    |    |        | (rev. 2)                          |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv15a  | N  | 8  | DSNAF. | Heart Failure Diagnosed:          |
| 65** |        | um |    |        | Condition diagnosed as            |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv16a  | N  | 8  | YNF.   | Diagnosed Since Last Visit:       |
| 66** |        | um |    |        | Diabetes Mellitus                 |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv16b  | N  | 8  | YNF.   | Diagnosed Since Last Visit:       |
| 67** |        | um |    |        | Bronchial Asthma                  |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv16c  | N  | 8  | YNF.   | Diagnosed Since Last Visit: Lower |
| 68** |        | um |    |        | GI Disorder                       |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv16d  | N  | 8  | YNF.   | Diagnosed Since Last Visit: Renal |
| 69** |        | um |    |        | Disorder                          |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv16e  | N  | 8  | YNF.   | Diagnosed Since Last Visit:       |
| 70** |        | um |    |        | Hepatobiliary Disease             |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv16f  | N  | 8  | YNF.   | Diagnosed Since Last Visit:       |
| 71** |        | um |    |        | Symptomatic Gout                  |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv16g  | N  | 8  | YNF.   | Diagnosed Since Last Visit:       |
| 72** |        | um |    |        | Malignant Neoplasia               |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv17   | N  | 8  | YNF.   | Hospitalized Since Last Study     |
| 73** |        | um |    |        | Visit                             |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv18   | N  | 8  | N      | NY Heart Assoc. Classification    |
| 74** |        | um |    | YHA1F. |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv19   | N  | 8  | L      | Current Life Style                |
| 75** |        | um |    | FSTLF. |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv20   | N  | 8  | IN     | Patient\'s Degree of Physical     |
| 76** |        | um |    | CDECF. | Activity Since Last Reported      |
|      |        |    |    |        | Visit                             |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv21   | N  | 8  | CS     | No. of Cigarettes Currently       |
| 77** |        | um |    | MKPDF. | smokes per Day                    |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv22a  | N  | 8  | YNF.   | Currently Smokes a Pipe           |
| 78** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv22b  | N  | 8  | YNF.   | Currently Smokes Cigars           |
| 79** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv23a  | N  | 8  | YNF.   | Used Since Last Study Visit: Oral |
| 80** |        | um |    |        | Anticoagulants                    |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv23b  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 81** |        | um |    |        | Heparin                           |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv23c  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 82** |        | um |    |        | Dipyridamole                      |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv23d  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 83** |        | um |    |        | Sulfinpyrazone                    |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv23e  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 84** |        | um |    |        | Aspirin                           |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv23f  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 85** |        | um |    |        | Aspirin-containing Medications    |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv24a  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 86** |        | um |    |        | Antacids                          |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv24b  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 87** |        | um |    |        | Anticholinergics                  |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv24c  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 88** |        | um |    |        | Insulin                           |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv24d  | N  | 8  | YNF.   | Used Since Last Study Visit: Oral |
| 89** |        | um |    |        | Hypoglycemic Agents               |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv24e  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 90** |        | um |    |        | Digitalis                         |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv24f  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 91** |        | um |    |        | Antiarrhythmic Agents             |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv24g  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 92** |        | um |    |        | Antihypertensives other than      |
|      |        |    |    |        | Diuretics                         |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv24h  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 93** |        | um |    |        | Nitroglycerin or Long-acting      |
|      |        |    |    |        | Nitrates                          |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv24i  | N  | 8  | YNF.   | Used Since Last Study Visit: Gout |
| 94** |        | um |    |        | Medication Other Than Probenecid  |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv24j  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 95** |        | um |    |        | Probenecid                        |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv24k  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 96** |        | um |    |        | Lipid-lowering drugs              |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv24l  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 97** |        | um |    |        | Phenylbutazone                    |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv24m  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 98** |        | um |    |        | Indomethacin                      |
+------+--------+----+----+--------+-----------------------------------+
| **   | fv24n  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 99** |        | um |    |        | Phenothiazines                    |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv24o  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 00** |        | um |    |        | Tricyclic Antidepressants         |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv24p  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 01** |        | um |    |        | Antihistamines                    |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv24q  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 02** |        | um |    |        | Propanolol                        |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv24r  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 03** |        | um |    |        | Corticosteroid                    |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv24s  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 04** |        | um |    |        | Tranquilizers                     |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv24t  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 05** |        | um |    |        | Hypnotics, Sedatives, Barbituates |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv24u  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 06** |        | um |    |        | Vitamins                          |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv24v  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 07** |        | um |    |        | Estrogens                         |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv24w  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 08** |        | um |    |        | Other Drugs                       |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv24x  | N  | 8  | YNF.   | Used Since Last Study Visit:      |
| 09** |        | um |    |        | Diuretics                         |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv24x1 | N  | 8  | DIURF. | If Used Diuretics, Why?           |
| 10** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv25   | N  | 8  | YNF.   | Was a Compound Containing         |
| 11** |        | um |    |        | Salicylate Derivatives Used in    |
|      |        |    |    |        | the Last Week                     |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv26a  | N  | 8  | YNF.   | Patient Used Drugs Supplied by    |
| 12** |        | um |    |        | Clinic: Acetaminophen             |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv26a1 | N  | 8  |        | No. of Capsules of Acetaminophen  |
| 13** |        | um |    |        | Since Last Visit                  |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv26b  | N  | 8  | YNF.   | Patient Used Drugs Supplied by    |
| 14** |        | um |    |        | Clinic: Propoxyphene              |
|      |        |    |    |        | Hydrochloride                     |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv26b2 | N  | 8  |        | No. of Capsules of Propoxyphene   |
| 15** |        | um |    |        | Hydrochloride Since Last Visit    |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27   | N  | 8  | ST     | Since Last Study Visit Has        |
| 16** |        | um |    | DMEDF. | Patient Reported Problems Related |
|      |        |    |    |        | to Study Medication               |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27a  | N  | 8  | YNF.   | Patient Reported: Difficulty      |
| 17** |        | um |    |        | Swallowing Capsules               |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27b  | N  | 8  | YNF.   | Patient Reported: Heartburn       |
| 18** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27c  | N  | 8  | YNF.   | Patient Reported: Stomach Pain    |
| 19** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27d  | N  | 8  | YNF.   | Patient Reported: Nausea w/o      |
| 20** |        | um |    |        | vomitting                         |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27e  | N  | 8  | YNF.   | Patient Reported: Vomitting       |
| 21** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27f  | N  | 8  | YNF.   | Patient Reported: Hematemesis     |
| 22** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27g  | N  | 8  | YNF.   | Patient Reported: Constipation    |
| 23** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27h  | N  | 8  | YNF.   | Patient Reported: Diarrhea        |
| 24** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27i  | N  | 8  | YNF.   | Patient Reported: Black Tarry     |
| 25** |        | um |    |        | Stools                            |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27j  | N  | 8  | YNF.   | Patient Reported: Bloody Stool    |
| 26** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27k  | N  | 8  | YNF.   | Patient Reported: Urticaria       |
| 27** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27l  | N  | 8  | YNF.   | Patient Reported: Other Types of  |
| 28** |        | um |    |        | Rash                              |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27m  | N  | 8  | YNF.   | Patient Reported: Dizziness       |
| 29** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27n  | N  | 8  | YNF.   | Patient Reported: Development or  |
| 30** |        | um |    |        | Worsening of Bronchial Asthma     |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv27o  | N  | 8  | YNF.   | Patient Reported: Other Problems  |
| 31** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv28a  | N  | 8  | YNF.   | Patient Has Experienced Since     |
| 32** |        | um |    |        | Last Study Visit (Prompted by     |
|      |        |    |    |        | Examiner): Symptoms Suggestive of |
|      |        |    |    |        | Peptic Ulcer, Gastritis or        |
|      |        |    |    |        | Erosion of Gastric Mucosa         |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv28b  | N  | 8  | YNF.   | Patient Has Experienced Since     |
| 33** |        | um |    |        | Last Study Visit (Prompted by     |
|      |        |    |    |        | Examiner): Hematemesis            |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv28c  | N  | 8  | YNF.   | Patient Has Experienced Since     |
| 34** |        | um |    |        | Last Study Visit (Prompted by     |
|      |        |    |    |        | Examiner): Black Tarry Stools     |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv28d  | N  | 8  | YNF.   | Patient Has Experienced Since     |
| 35** |        | um |    |        | Last Study Visit (Prompted by     |
|      |        |    |    |        | Examiner): Bloody Stools          |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv29e  | N  | 8  | YNF.   | Prescription Changes Made in      |
| 36** |        | um |    |        | Medication?                       |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv30a  | N  | 8  | RE     | Reason For Reduced Prescription:  |
| 37** |        | um |    | DPREF. | Main Reason                       |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv31   | N  | 8  |        | Total Number of Capsules          |
| 38** |        | um |    |        | Prescribed Since Last Study Visit |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv32   | N  | 8  |        | Total Number of Capsules Taken    |
| 39** |        | um |    |        | Since Last Study Visit            |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33   | N  | 8  | MEDSF. | Did patient Take Number of        |
| 40** |        | um |    |        | Capsules Prescribed?              |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33a  | N  | 8  | MRNAF. | If No, Main Reason Was:           |
| 41** |        | um |    |        | Forgetfullness or Other           |
|      |        |    |    |        | Non-medical Reason                |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33b  | N  | 8  | MRNAF. | If No, Main Reason Was:           |
| 42** |        | um |    |        | Unwillingness/Refusal to Take     |
|      |        |    |    |        | Prescribed Medication             |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33c  | N  | 8  | MRNAF. | If No, Main Reason Was:           |
| 43** |        | um |    |        | Difficulty in Swallowing Capsules |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33d  | N  | 8  | MRNAF. | If No, Main Reason Was: Heartburn |
| 44** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33e  | N  | 8  | MRNAF. | If No, Main Reason Was: Stomach   |
| 45** |        | um |    |        | Pain                              |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33f  | N  | 8  | MRNAF. | If No, Main Reason Was: Nausea    |
| 46** |        | um |    |        | w/o Vomitting                     |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33g  | N  | 8  | MRNAF. | If No, Main Reason Was: Vomitting |
| 47** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33h  | N  | 8  | MRNAF. | If No, Main Reason Was:           |
| 48** |        | um |    |        | Hematemesis                       |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33i  | N  | 8  | MRNAF. | If No, Main Reason Was:           |
| 49** |        | um |    |        | Constipation                      |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33j  | N  | 8  | MRNAF. | If No, Main Reason Was: Diarrhea  |
| 50** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33k  | N  | 8  | MRNAF. | If No, Main Reason Was: Back      |
| 51** |        | um |    |        | Tarry Stools                      |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33l  | N  | 8  | MRNAF. | If No, Main Reason Was: Bloody    |
| 52** |        | um |    |        | Stools                            |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33m  | N  | 8  | MRNAF. | If No, Main Reason Was: Urticaria |
| 53** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33n  | N  | 8  | MRNAF. | If No, Main Reason Was: Other     |
| 54** |        | um |    |        | Types of Rash                     |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33o  | N  | 8  | MRNAF. | If No, Main Reason Was: Dizziness |
| 55** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33p  | N  | 8  | MRNAF. | If No, Main Reason Was:           |
| 56** |        | um |    |        | Development or Worsenning of      |
|      |        |    |    |        | Bronchial Asthma                  |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33q  | N  | 8  | MRNAF. | If No, Main Reason Was: Unable to |
| 57** |        | um |    |        | Determine Reason                  |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv33r  | N  | 8  | MRNAF. | If No, Main Reason Was: Other     |
| 58** |        | um |    |        | Problems                          |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv34a  | N  | 8  | YESF.  | No Study Medication or            |
| 59** |        | um |    |        | Single-blind Placebo Prescribed   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv35   | N  | 8  | YNF.   | Has Sealed Medication Code Been   |
| 60** |        | um |    |        | Broken                            |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv36   | N  | 8  |        | Weight (lbs.)                     |
| 61** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv37a  | N  | 8  |        | SBP (mm Hg)                       |
| 62** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv37b  | N  | 8  |        | DBP (mm Hg)                       |
| 63** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv38   | N  | 8  |        | Pulse Rate (beats per minute)     |
| 64** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv39   | N  | 8  | YNF.   | Rhythm Regular                    |
| 65** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv40a  | N  | 8  | YNF.   | Findings Present: Peripheral      |
| 66** |        | um |    |        | Edema                             |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv40b  | N  | 8  | YNF.   | Findings Present: Ventricular     |
| 67** |        | um |    |        | Diastolic Gallop                  |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv40c  | N  | 8  | YNF.   | Findings Present: Basilar Rales   |
| 68** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv41a  | N  | 8  | YNF.   | Findings Present: Epigastric      |
| 69** |        | um |    |        | Tenderness                        |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv41b  | N  | 8  | YNF.   | Findings Present: Hepatomegaly    |
| 70** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv41c  | N  | 8  | YNF.   | Findings Present: Splenomegaly    |
| 71** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv44b  | N  | 8  |        | Time Urine Specimen Collected:    |
| 72** |        | um |    |        | Hour                              |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv44c  | N  | 8  |        | Time Urine Specimen Collected:    |
| 73** |        | um |    |        | Minutes                           |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv44d  | N  | 8  | AMPMF. | Time Urine Specimen Collected:    |
| 74** |        | um |    |        | AM/PM                             |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv45   | N  | 8  | HR     | Hours Between Drug Dose and       |
| 75** |        | um |    | SBETF. | Collection of Urine Specimen      |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv46   | N  | 8  | NPF.   | Hematuria                         |
| 76** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv47   | N  | 8  | NPF.   | Urine Glucose                     |
| 77** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv48   | N  | 8  |        | Urine Protein                     |
| 78** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv50   | N  | 8  | YNF.   | Patient Scheduled for Interim     |
| 79** |        | um |    |        | Urine Salicylate Determination    |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv51b  | N  | 8  |        | Time: Hour                        |
| 80** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv51c  | N  | 8  |        | Time: Minutes                     |
| 81** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv51d  | N  | 8  | AMPMF. | Time: AM/PM                       |
| 82** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv52   | N  | 8  |        | Hematocrit (%)                    |
| 83** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv53   | N  | 8  | YNF.   | Platelet Aggregation Test         |
| 84** |        | um |    |        | Performed                         |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv54   | N  | 8  |        | Platelet Count (cells/mm3)        |
| 85** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv55a1 | N  | 8  |        | Prothrombin Activity: Patient\'s  |
| 86** |        | um |    |        | Value: Seconds                    |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv55a2 | N  | 8  |        | Prothrombin Activity: Patient\'s  |
| 87** |        | um |    |        | Value: Percent                    |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv55b1 | N  | 8  |        | Prothrombin Activity: Normal      |
| 88** |        | um |    |        | (Control) Value: Seconds          |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv55b2 | N  | 8  |        | Prothrombin Activity: Normal      |
| 89** |        | um |    |        | (Control) Value: Percent          |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv56a  | N  | 8  |        | Partial Thromboplastin: Time:     |
| 90** |        | um |    |        | Patient\'s Value: Seconds         |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv56b1 | N  | 8  |        | Partial Thromboplastin: Time:     |
| 91** |        | um |    |        | Normal (Control) Value: From (in  |
|      |        |    |    |        | seconds)                          |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv56b2 | N  | 8  |        | Partial Thromboplastin: Time:     |
| 92** |        | um |    |        | Normal (Control) Value: To (in    |
|      |        |    |    |        | seconds)                          |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv57   | N  | 8  | YNF.   | Physician\'s Opinion: Does        |
| 93** |        | um |    |        | Coagulation Profile Containdicate |
|      |        |    |    |        | Patient\'s                        |
|      |        |    |    |        |                                   |
|      |        |    |    |        | Continued Prescription of Study   |
|      |        |    |    |        | Medication                        |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv58   | N  | 8  |        | White Blood Cell Count            |
| 94** |        | um |    |        | (cells/mm3)                       |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv61a  | N  | 8  | D      | Chest X-ray: Cardiomegaly         |
| 95** |        | um |    | NPNAF. |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv61b  | N  | 8  | D      | Chest X-ray: Pleural Effusion     |
| 96** |        | um |    | NPNAF. |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | fv61c  | N  | 8  | D      | Chest X-ray: Pulmonary Congestion |
| 97** |        | um |    | NPNAF. |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | mvrev  | N  | 8  |        | Missed Visit Form Revision        |
| 98** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **1  | mv08a  | N  | 8  | NSPDF. | Events or Procedures Performed:   |
| 99** |        | um |    |        | Myocardial Infarction             |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv08b  | N  | 8  | NDF.   | Events or Procedures Performed:   |
| 00** |        | um |    |        | Angina Pectoris or Other Chest    |
|      |        |    |    |        | Pain Related to Ischemic Heart    |
|      |        |    |    |        | Disease Requiring Hospitalization |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv08c  | N  | 8  | NDF.   | Events or Procedures Performed:   |
| 01** |        | um |    |        | Angina Pectoris Not Requiring     |
|      |        |    |    |        | Hospitalization                   |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv08d  | N  | 8  | NSPDF. | Events or Procedures Performed:   |
| 02** |        | um |    |        | Stroke                            |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv08e  | N  | 8  | NSPDF. | Events or Procedures Performed:   |
| 03** |        | um |    |        | Intermittent Cerebral Aschemic    |
|      |        |    |    |        | Attack                            |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv08f  | N  | 8  | NSPDF. | Events or Procedures Performed:   |
| 04** |        | um |    |        | Peripheral Arterial Occlusion     |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv08g  | N  | 8  | NSPDF. | Events or Procedures Performed:   |
| 05** |        | um |    |        | Intermittent Claudication         |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv08h  | N  | 8  | NSPDF. | Events or Procedures Performed:   |
| 06** |        | um |    |        | Pulmonary Embolism                |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv08i  | N  | 8  | NDF.   | Events or Procedures Performed:   |
| 07** |        | um |    |        | Cardiovascular Surgery            |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv08j  | N  | 8  | NDF.   | Events or Procedures Performed:   |
| 08** |        | um |    |        | Gastrointestinal Disorder         |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv08k  | N  | 8  | NDF.   | Events or Procedures Performed:   |
| 09** |        | um |    |        | Coronary Arteriography            |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv08l  | N  | 8  | NS     | Events or Procedures Performed:   |
| 10** |        | um |    | DUNAF. | Heart Failure                     |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv09   | N  | 8  | YNF.   | Patient Hospitalized Since Last   |
| 11** |        | um |    |        | Visit                             |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv10   | N  | 8  | YNF.   | Study Medication Discontinued     |
| 12** |        | um |    |        |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv10b  | N  | 8  | DI     | Reason For Discontinuation: Main  |
| 13** |        | um |    | SCONF. | Reason                            |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv10c  | N  | 8  | DI     | Reason For Discontinuation:       |
| 14** |        | um |    | SCONF. | Additional Reason 1               |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv10d  | N  | 8  | DI     | Reason For Discontinuation:       |
| 15** |        | um |    | SCONF. | Additional Reason 2               |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv10e  | N  | 8  | DI     | Reason For Discontinuation:       |
| 16** |        | um |    | SCONF. | Additional Reason 3               |
+------+--------+----+----+--------+-----------------------------------+
| **2  | mv10f  | N  | 8  | DI     | Reason For Discontinuation:       |
| 17** |        | um |    | SCONF. | Additional Reason 4               |
+------+--------+----+----+--------+-----------------------------------+
| **2  | fv36c  | N  | 8  | CL     | Collapsed Value                   |
| 18** |        | um |    | LPSEF. |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **2  | fv37ac | N  | 8  | CL     | Collapsed Value                   |
| 19** |        | um |    | LPSEF. |                                   |
+------+--------+----+----+--------+-----------------------------------+
| **2  | fv37bc | N  | 8  | CL     | Collapsed Value                   |
| 20** |        | um |    | LPSEF. |                                   |
+------+--------+----+----+--------+-----------------------------------+